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Preserving Life's Memories 
Alzheimer's Research at BUSM 
J L J L o p c and p r o m i s e . T h e r e are those w h o say t h a t h i i r i e d deep ins ide a 
c o l d , d a r k Bos ton w i n t e r lie the h o p e a n d p r o m i s e o f m a n y a B o s t o n i a n . Each 
passing day Br ings closer the real i ty o f spring 's new l i f e . 
S i m i l a r l y , t i ie w i n t e r e d i t i o n o f BU Medicine is f i l l e d w i t h examples o f b o t h the 
h o p e a n d p r o m i s e present at Boston U n i v e r s i t y School o f M e d i c i n e ( B U S M ) . We 
f i n d h o p e , f o r example , in the m u l t i f a c e t e d A l z h e i m e r ' s disease ( A D ) research 
studies u n d e r way at the school . These teams o f invest igators are t a k i n g d i f f e r e n t 
approaches to the s t u d y o f y \ l ) , b u t the c o m b i n e d object ive is to better u n d e r -
s tand a n d manage A D , b r i n g i n g hope to those a f f l i c ted as w e l l as t h e i r f ami l i es . 
1 l o p e can also he f o u n d i n the w o r k o f o u r new col league, Joseph Tsien, P h D , 
w h o has b r o u g h t to Bos ton U n i v e r s i t y ( B U ) his d e c a d e - l o n g quest t o discover 
the keys to m e m o r y . Tsien's research, w h i c h d r a w s o n the ski l ls o f researchers 
f r o m b o t h BU's School o f M e d i c i n e a n d Col lege o f E n g i n e e r i n g , a i m s t o m a k e 
even greater str ides t o w a r d u n d e r s t a n d i n g h o w m e m o r y is f o r m e d , processed, 
a n d s tored . 
T h e p r o m i s e o f o u r i n s t i t u t i o n is c lear ly a p p a r e n t i n t h e faces o f t h e B U S M 
students . By consistently s t r i v i n g f o r a diverse s tudent b o d y we aspire t o prepare 
o u r s tudents t o f u l t l l l t h e i r roles as f u t u r e d o c t o r s w h o can treat a n d care f o r 
people f r o m all d i f f e r e n t b a c k g r o u n d s . Promise is also e v i d e n t i n the t r e m e n -
d o u s talents d isplayed b y f o u r o f o u r G r a d u a t e M e d i c a l Sciences s tudents . I f the 
impress ive h a n d s - o n l a b o r a t o r y w o r k already a c c o m p l i s h e d b y these s tudents is 
any i n d i c a t i o n , t h e y w i l l someday lead the e x p e r i m e n t s t i i a t c t ) n t i n u e t o b r i n g 
h o p e t o society. 
k i k e Bostonians m a k i n g t h e i r w a y t h r o u g h a n o t h e r N e w E n g l a n d w i n t e r , w e are 
c o n f i d e n t that the di l igence a n d perseverance s h o w n b y o u r facu l ty a n d s tudents 
today w i l l lead to the b r e a k t h r o u g h s a n d leaders o f t o m o r r o w . 
Sincerely, 
John M c C a h a n , M D 
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Tackling Alzheimer's Disease 
BUSM investigators are working diligently to defeat this devastating disease. 
The Changing Faces of BUSM 
Less than 10 years ago, the student body was mostly white males. 
Times have changed. 
On a Mission to Comprehend Memory 
Joseph Tsien, PhD, plans to tap deep into the talents at BU to further his 
studies into how memory works. 
12 
The Next Generation of Researchers 
A desire to understand drives the research of students i n the 
Division of Graduate Medical Sciences. 
16 
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Alzheimer's disease can turn a 
vibrant person into a lifeless 
shell. But BUSM investigators 
are working diligently to defeat 
this devastating disease. 
As sun pours in through a nearby window, 
a woman sits hunched over i n her chair, f i t ful ly 
sleeping. Once a slim and active redhead, during 
the past two years she has transformed into a 
gray-haired, doughy-hodied shell o f her former 
self. She doesn't move w i t h o u t prodding, and 
then only for short distances. Most o f the time 
she sleeps. When she is awake, she doesn't recog-
nize anyone or register much of anything. Her 
hushand, after several years o f watching his wife 
deteriorate, has finally come to terms w i t h the 
fact that she has Alzheimer's disease. 
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Disease The most c o m m o n f o r m o f d e m e n t i a , Alzheimer 's disease ( A D ) is a progressive b r a i n disorder. As the disease takes over, v i c t i m s lose their memor ies and abilities to learn , reason, a n d c o m m u n i c a t e . Simple dai ly activit ies , l ike ge t t ing 
dressed or t a k i n g a shower, become t o o d i f f i c u l t 
to p e r f o r m o n their o w n . A D affects as m a n y as 
4.5 m i l l i o n Amer icans , according t o the N a t i o n a l 
Ins t i tute o n A g i n g ( N I A ) . N e a r l y h a l f o f those 
aged 85 and older may have the disease, a l t h o u g h 
scientists stress A D is n o t a n o r m a l p a r t o f aging. 
Researchers do n o t f u l l y unders tand w h a t causes 
A D , b u t they are m a k i n g progress. 
A t Boston Univers i ty School o f M e d i c i n e 
( B U S M ) , b o t h basic science a n d c l in ica l research 
i n t o A D have been o n g o i n g for m o r e t h a n a 
decade. T h e n i n 1996 B U S M w o n an N I A grant 
to open an Alzheimer 's Disease Center ( A D C ) , 
one o f 29 such na t iona l centers focus ing o n 
research, educat ion , a n d c l in ica l care for A D . N e i l 
K o w a l l , M D , director o f the A D C a n d professor 
o f n e u r o l o g y a n d p a t h o l o g y a n d l a b o r a t o r y m e d -
ic ine, is the p r i n c i p a l investigator o f the grant . 
" ITaving an A D C designates us as a t o p - l e v e l cen-
ter for Alzheimer 's research nat ional ly , " says 
K o w a l l . " I t h i n k i t makes i t easier f o r o u r invest i -
gators to w i n f u n d i n g for the i r studies, a n d i t 
allows us to attract t o p - n o t c h talent ." 
The A D C , w h i c h has locat ions at the m e d -
ical school a n d the E d i t h N o u r s e Rogers V A 
H o s p i t a l i n B e d f o r d , Mass., consists o f five cores. 
A t the heart is the c l in ica l core, d irected by 
Robert Green, M D , M P H , professor o f neurology , 
medic ine , and epidemiology, a n d Rober t Stern, 
P h D , associate professor o f neuro logy . K n o w n as 
H O P E ( H e a l t h Outreach P r o g r a m f o r the 
E lder ly ) , the c l inical core recruits people w i t h 
a n d w i t h o u t A D for research. C u r r e n t l y , H O P E 
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has ahout 550 people w h o are annual ly 
assessed and characterized, a n d the i r 
i n f o r m a t i o n is entered i n t o a database. 
Investigators at B U S M a n d t h r o u g h o u t 
the region can use the f i O P E database 
to f i n d subjects for the i r tr ia ls . 
"Investigators tel l us w h a t k i n d o f sub-
jects they need, and we help p r o v i d e 
them," says K o w a l l . 
The other f o u r cores inc lude a n e u -
ropathology core, r u n by A n n McKee , 
M D , associate professor o f n e u r o l o g y 
and pathology and l a b o r a t o r y medic ine . 
This core receives b r a i n donat ions , o n 
w h i c h McKee p e r f o r m s autopsies. Af te r 
she assesses the brains , the i n f o r m a t i o n 
is entered i n t o a database that 
researchers can access for the i r studies. 
The database, w h i c h is also p a r t o f a 
nat ional n e t w o r k , contains several h u n -
dred samples. Investigators w o r k i n g i n 
the transgenic mouse co lony core per-
f o r m A D - r e l a t e d research o n mice , the 
results o f w h i c h are available to o ther 
investigators. The educat ion core, r u n b y 
Kathy H o r h a t h , P h D , R N , a n d Rose 
Harvey, PhD, R N , encourages research 
study recru i tment and provides outreach 
programs; H o r h a t h a n d H a r v e y travel to 
various c o m m u n i t i e s a n d ta lk ahout 
Alzheimer's disease. They also r u n A D -
related conferences. The f i n a l core, 
w h i c h is adminis t ra t ive , coordinates al l 
o f the center's activities. 
O n e o f the m a i n purposes o f the 
A D C is to encourage, facilitate, and syn-
ergize A D research at B U S M a n d also 
t h r o u g h o u t the region , according to 
Green. "It 's a very interest ing concept. 
We help others get started w i t h the i r 
research and help t h e m be successful," 
he says. "For example, we p r o v i d e inves-
tigators w i t h patients, neuropsychology 
data, and b r a i n tissue or b l o o d . So a 
w h o l e host o f scientists come to us w i t h 
m a n y dif ferent k inds o f requests." 
I n accordance w i t h this miss ion, the 
A D C offers a p i l o t project p r o g r a m that 
helps investigators develop their 
research. "We f u n d investigators to test 
new ideas. It's l ike an abbreviated version 
o f an N I H grant," explains K o w a l l , w h o 
says the p r o g r a m has been very success-
f u l to date. "Every year we receive a r o u n d 
10 to 12 applications, and we f u n d t w o 
grants. A l m o s t al l o f o u r p i l o t grantees 
have gone o n to receive f u r t h e r f u n d i n g , 
and ail o f the investigators have p u b -
lished papers i n peer-reviewed journals . " 
A d d i t i o n a l l y , the A D C w o r k s i n 
par tnership w i t h other A D C s n a t i o n -
w i d e , sharing ideas and research results, 
as w e l l as c o n d u c t i n g col laborative s t u d -
ies. A l l o f these activities are coordinated 
by the N a t i o n a l Alzheimer 's C o o r d i n a t -
i n g Center at the Univers i ty o f Washing-
t o n i n Seattle. 
A t B U S M , the A D C has a synergis-
t ic re la t ionship w i t h m a n y o f the ongo-
i n g Alzheimer ' s studies, especially i n the 
area o f c l in ica l research. Cl in ica l investi-
gators a n d the A D C of ten w o r k together, 
shar ing data, intel lect , patients, or 
resources. F o u r o f the most c o m p e l l i n g 
projects c u r r e n t l y u n d e r way include the 
E r a m i n g h a m H e a r t Study (EHS), 
M I R A G E ( M u l t i - I n s t i t u t i o n a l Research 
i n Alzheimer 's Genetic E p i d e m i o l o g y ) , 
REVEAE (Risk Evaluat ion and 
E d u c a t i o n for Alzheimer ' s Disease), and 
A D A P T (Alzheimer 's Disease A n t i -
i n f l a m m a t o r y Prevent ion Tr ia l ) . 
A l t h o u g h the EHS is best k n o w n for 
its cardiovascular research, w h i c h has 
been o n g o i n g since 1948, i t is also h ighly 
respected for its dement ia studies. Phi l ip 
W o l f , M D , professor o f neurology, epi -
demiology, and biostatistics, has been 
w i t h the EHS since 1967 and its p r i n c i p a l 
investigator since 1988. He explains that 
the EHS is l o n g i t u d i n a l a n d epidemio-
logical , w h i c h means i t studies disease i n 
a selected g r o u p o f people for many 
years (three generations o f Eramingham 
families n o w take par t i n the s tudy) . 
C u r r e n t l y , the EHS has three grants 
related to dement ia a n d A D (one o f 
w h i c h was p e n d i n g c o n t i n u e d f u n d i n g 
at press t i m e ) . S t u d y i n g dement ia and 
A D seemed l ike a logical progression for 
the EHS, says W o l f . "As o u r cohor t aged, 
we were seeing m o r e a n d m o r e cases o f 
dement ia a n d A D , " he says, " b o t h o f 
w h i c h are o f great interest i n the medical 
c o m m u n i t y . " 
I n i t i a l l y , the EHS was s i m p l y t r y i n g 
to i d e n t i f y people w i t h moderate to 
severe dement ia , says Rhoda A n , PhD, 
w h o runs t w o o f the EHS dementia 
studies and is a research assistant profes-
sor o f neurology. N e x t , researchers 
str ived to accurately diagnose m i l d 
dement ia . M o r e recently, they are w o r k -
Robert Green, MD, MPH (middle), works 
on the Framingham Heart Study (FHS) with 
Philip Wolf, MD, the FHS principal investi-
gator, and Rhoda Au, PhD, who runs two 
of the FHS dementia studies. 
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i n g to i d e n t i f y people w i t h m i l d cogni -
tive i m p a i r m e n t , w h i c h is considered a 
prec l in ica l stage o f A D . 
" T h e diagnost ic cr i ter ia for m i l d 
cogni t ive i m p a i r m e n t are s t i l l very m u c h 
u p i n the air," explains A u , w h o says the 
F H S is w o r k i n g w i t h members o f the 
A D C to def ine this new area. " I t is the 
b e g i n n i n g stages o f Alzheimer 's disease 
at its very earliest, before there are really 
any t r u e c l in ica l s y m p t o m s . The idea is 
tha t p r e v e n t i o n a n d i n t e r v e n t i o n at the 
earlier stages w o u l d be m o r e effective." 
F r a m i n g h a m investigators are also 
t r y i n g to d e t e r m i n e whether a n u m b e r 
o f cardiovascular r isk factors are l i n k e d 
to d e m e n t i a a n d A D . Some o f the study's 
f i n d i n g s t h r o u g h o u t the years inc lude 
possible l i n k s between h i g h b l o o d pres-
sure a n d h i g h homocyste ine levels and 
cogni t ive decline. "We're certainly seeing 
tha t a n u m b e r o f cardiovascular r isk fac-
tors are l i n k e d to c o g n i t i o n and maybe 
some deficits i n c o g n i t i o n . So n o w the 
quest ion we are p u r s u i n g is whether that 
goes d o w n the c o n t i n u u m to A D , " says A u . 
As p a r t o f another grant , 
F r a m i n g h a m investigators p e r f o r m e d 
neuropsychologica l testing and M R I 
scans o n ahout 3,000 o f the o f f s p r i n g 
f r o m the study's o r i g i n a l cohor t . "We're 
l o o k i n g at changes i n the M R I , " says A u , 
" a n d t r y i n g to see i f that's predict ive o f 
cogni t ive decline." 
As i t t u r n s o u t , par t ic ipants w i t h 
cer ta in r i sk factors that were measured 
years b e f o r e — l i k e h i g h b l o o d pressure, 
s m o k i n g , a n d diabetes—had smaller 
bra ins a n d p e r f o r m e d m o r e p o o r l y o n 
the neuropsychologica l tests, according 
to W o l f . " T h e y weren't demented , h u t i t 
w o u l d p r o b a b l y he i n the i r best interest 
to reduce the i r risks to t r y to prevent 
cogni t ive decline i n the f u t u r e , " he says. 
W h e n i t comes to the FHS, the goal 
is always prevent ion, adds A u . "The con-
cept o f risk factors was actually coined by 
F r a m i n g h a m as wel l as the idea that there 
are modi f iah le behaviors that can decrease 
y o u r risk for disease," she says. "One o f 
the most i m p o r t a n t f indings f r o m the 
F r a m i n g h a m study is that your health at 
m i d l i f e matters. I t not o n l y affects your 
heart or your risk o f stroke, h u t also your 
cognitive funct ions later i n life." 
Like the FHS, M I R A C E is e p i d e m i -
ological , a l t h o u g h his tor ica l ly i t is cross-
sectional, n o t l o n g i t u d i n a l , m e a n i n g 
par t ic ipants are k n o w n to have A D a n d 
the i r i n f o r m a t i o n is gathered at one 
p o i n t i n t i m e . Lindsay Earrer, P h D , 
B U S M professor o f medic ine , neurology, 
MIRAGE is the largest 
family-based epidemiological ; 
study of Alzheimer's disease 
in the world today. Lindsay 
Farrer, PhD, was a driving 
j force behind its creation and 
has been the principal j 
investigator since its initial 
funding in 1991. 
and genetics and genomics. School o f 
Publ ic H e a l t h professor o f biostatistics 
and epidemiology , a n d chief o f the 
Cenetics P r o g r a m , was a d r i v i n g force 
b e h i n d M I R A C E a n d has been the p r i n -
cipal investigator since its i n i t i a l f u n d i n g 
i n 1991. W o r k i n g o n the genetics o f 
Alzheimer 's hack i n the 1980s, Farrer 
says he and his colleagues realized that 
s t u d y i n g a few h u n d r e d famil ies w o u l d 
n o t he suff ic ient i n the i r quest to 
unravel the mysteries o f A D . " I had an 
idea. Let's see i f we can get a g r o u p o f 
researchers l ike us w h o have access to 
large n u m b e r s o f famil ies and w h o have 
an interest i n the genetic issues, and let's 
w o r k together," says Earrer. 
Thus began M I R A C E , w h i c h today is 
the largest family-based epidemiological 
study o f A D i n the w o r l d . It's f u n d e d by 
the N I A and includes 14 field sites, and its 
database has i n f o r m a t i o n o n almost 3,000 
families—30,000 to 35,000 indiv iduals . 
Investigators have collected D N A speci-
mens f r o m more than 1,500 part ic ipants . 
"The major theme o f the study, w h i c h is 
the major theme o f m y research, is under-
standing the genetic basis o f Alzheimer's 
disease and, more broadly, unders tanding 
the interdigi tat ion between genetic and 
nongenetic factors," says Farrer. "There is 
no one factor that is responsible for the 
disease. Alzheimer's disease, l ike most 
c o m m o n complex diseases, has m u l t i p l e 
risk factors." 
D u r i n g its 13 years o f invest igat ion , 
M I R A C E has c o n t r i b u t e d greatly to the 
s tudy o f A D . Some o f its key f i n d i n g s 
inc lude d e m o n s t r a t i n g tha t genetic fac-
tors indeed play a m a j o r role i n the 
development o f A D , the strongest r i sk 
factor i d e n t i f i e d thus far b e i n g the e4 
var iant o f a p o l i p o p r o t e i n E ( A P O E ) ; 
investigators have also s h o w n tha t the 
presence o f this v a r i a n t is m o r e weakly 
associated w i t h disease i n m e n , people 
older t h a n 75, and several groups o f 
n o n - E u r o p e a n descent, i n c l u d i n g 
A f r i c a n Amer icans . ( M I R A C E has the 
largest data set o f A f r i c a n A m e r i c a n 
families and A D i n the w o r l d a n d has 
publ i shed several papers o n the subject.) 
Creen has w o r k e d w i t h Earrer as co-
p r i n c i p a l investigator for M I R A C E . " T h e 
M I R A C E study has characterized, w i t h 
some precision, the r isk that a f a m i l y 
member has w h e n someone i n the f a m i l y 
has Alzheimer 's disease," he says, "so i f 
y o u had a mother , father, brother , or sis-
ter w i t h Alzheimer 's disease, a n d y o u 
came to y o u r doc tor a n d asked 'what's 
m y risk,' instead o f t a l k i n g i n generalities 
we can n o w talk m u c h m o r e specifically 
and show y o u r isk curves and explain to 
y o u w h a t that r isk is. We are n o w start-
i n g to be able to define those risks, w h i c h 
are di f ferent i f y o u are male or female, i f 
y o u are w h i t e or black, and d e p e n d i n g 
o n y o u r age. So we've really been able to 
characterize r isk curves. 
" M I R A C E has also e x a m i n e d a 
n u m b e r o f d i f ferent r i sk factors i n c o m -
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b i n a t i o n — h e a d t r a u m a , nonstero ida l 
a n t i - i n f l a m m a t o r i e s , the r isk according 
to A P O E genotype, e t h n i c i t y — a l l o f 
those things have been p u b l i s h e d b y the 
M I R A G E study and have c o n t r i b u t e d to 
our unders tanding o f r isk factors for 
Alzheimer's disease," says Green. 
The current phase o f M I R A G E , 
w h i c h was f u n d e d for another five years 
i n 2002, focuses o n questions related to 
the vascular basis o f A D . "Over the last 
five to 10 years, there's been a g r o w i n g 
b o d y o f evidence—genetic, e p i d e m i o -
logical , pathological , a n d c l in ica l s t u d -
ies—suggesting that w h a t we call 
vascular r isk factors are also r isk factors 
for A D , " says Farrer. 
He notes how, paradoxically, diag-
nosticians for years drew a l ine between 
different major forms o f dementia . "The 
dogma had been that vascular dementia 
goes one way and A D goes another," says 
Earrer. " B u t what is n o w b e c o m i n g recog-
nized is that vascular r isk factors, w h i c h 
may lead to vascular dementia , m a y also 
contribute to Alzheimer's disease." 
For this phase o f the study, invest i -
gators are col lect ing i n f o r m a t i o n a n d 
b l o o d samples n o t o n l y f r o m people 
w i t h A D , b u t f r o m other f a m i l y m e m -
bers i n c l u d i n g at least one l i v i n g n o n d e -
m e n t e d s ib l ing. A d d i t i o n a l l y , a l l 
part ic ipants undergo an M R I o f their 
brains . The goal is to i d e n t i f y genes that 
are i n the vascular pathway—genes 
related to vascular f u n c t i o n — a n d test to 
see i f they are associated n o t o n l y w i t h 
disease, b u t also w i t h precursors to dis-
ease, says Earrer. " W h a t we w a n t to be 
able to do i n this p a r a d i g m is disentan-
gle changes that m a y n o t be related to 
disease, b u t m i g h t be heritable, f r o m 
ones that also may be heritable b u t are 
related to disease," he says. 
Earrer is also a p p l y i n g for supple-
m e n t a l funds to enhance the research 
using data collected o n the n o n d e m e n -
ted siblings. Current ly , investigators c o n -
d u c t a b r i e f telephone i n t e r v i e w o f these 
siblings as a cognit ive screen. The in ter -
v iew is h i g h l y sensitive for d i s c r i m i n a t -
i n g people w h o are d e m e n t e d f r o m 
those w h o are n o t , says Farrer, b u t not 
sensitive e n o u g h to t rack smal l cognitive 
changes i n m e m o r y a n d abi l i ty . Earrer 
wants to give a p p r o x i m a t e l y 400 o f the 
n o n d e m e n t e d siblings a battery o f neuro-
psychological exams. " T h i s w i l l provide 
us w i t h a wea l th o f i n f o r m a t i o n and 
a l low us to do all sorts o f comparisons," 
says Earrer. " B u t m o r e i m p o r t a n t , we 
v i e w this as the basis for the fu ture o f 
the M I R A G E study. We w o u l d use these 
data to begin a l o n g i t u d i n a l f o l l o w - u p o f 
these h i g h - r i s k people. We and others 
w i l l be i d e n t i f y i n g genes for A D , and 
then we 'd start to t rack people. This is 
o u r hope." 
B u i l d i n g o n the r i sk data discovered 
i n M I R A G E , Green, a long w i t h Scott 
Roberts, P h D , assistant professor o f neu-
rology, he lped devise R E V E A L , the f irst 
r a n d o m i z e d c l in ica l t r i a l to share r isk-
factor assessments, i n c l u d i n g genetic 
disclosure, w i t h a t - r i sk f a m i l y members. 
"We w a n t e d to k n o w w h a t the impact 
w o u l d be o n the i r a t t i tude , their psy-
chology, w h e t h e r or n o t they b u y insur-
ance, whether they take measures to t r y 
and protect themselves health-wise, 
a l t h o u g h there are a l i m i t e d n u m b e r o f 
things y o u can do for Alzheimer 's dis-
ease at this p o i n t , " says Green, w h o is 
p r i n c i p a l investigator. 
The study, w h i c h is f u n d e d by the 
N a t i o n a l H u m a n G e n o m e Research 
Ins t i tu te a n d the N I A , examined 162 
adul t c h i l d r e n o f people w i t h A D . One 
g r o u p received r isk assessments based 
o n age, sex, and f a m i l y history. I n the 
other g r o u p , A P O E genotype was also 
disclosed, i n c l u d i n g whether or n o t par-
t ic ipants carr ied the e4 var iant o f A P O E , 
w h i c h raises the r isk o f developing A D . 
For the m a j o r i t y o f par t ic ipants , disclo-
sure o f r i sk d i d n o t increase anxiety 
ahout developing A D , even for those 
w h o learned they h a d the unfavorable 
A P O E genotype. Risk disclosure tended 
to reduce anxiety a m o n g part ic ipants 
w i t h A P O E £4 negative results. 
BUSM takes part in new AD study 
This past fall Boston University School 
of Medicine (BUSM) announced it will 
take part in a new $60-million, five-
year study called the Alzheimer's 
Disease Neuroimaging Initiative. 
Investigators will use magnetic reso-
nance imaging (MRI) and positron 
emission tomography (PET) scans to 
study how brains change as mild cogni-
tive impairment (MCI), a preclinical 
stage to Alzheimer's disease (AD), and 
AD progress. They'll also correlate this 
imaging information with biological 
markers, as well as clinical and neuro-
psychological assessments. By combin-
ing this data, researchers hope to 
develop better treatments for AD and 
monitor their effectiveness; they also 
hope to lessen the length and cost of 
clinical trials. 
BUSM is one of 50 sites for the proj-
ect, which is funded by the National 
Institute on Aging (NIA) in conjunction 
with other federal agencies, private 
companies, and organizations. 
Investigators will recruit approximately 
800 adults nationwide, ages 55 to 90, 
for the project, following about 200 
cognitively normal people for three 
years, 400 with MCI for three years, 
and 200 people with AD for two years. 
Ronald Killiany, PhD, co-principal inves-
tigator of the project at BUSM and 
assistant professor of anatomy and 
neurobiology, believes this initiative 
represents a tremendous opportunity 
to find new targets for therapies and 
help position researchers to test the 
next generation of treatments to pre-
vent and delay AD. 
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"We t h i n k risk assessment and c o m -
m u n i c a t i o n o f r isk assessment is going to 
he very i m p o r t a n t i n the next few years as 
we develop treatments for Alzheimer's ," 
says Green. " W h e n treatments are devel-
oped, it's go ing to become very i m p o r t a n t 
to he able to define risk. Because i f y o u 
are at h i g h r isk, you're going to want to 
take a preventive treatment , even i f it's 
expensive or has side effects. I f y o u are 
n o t at h i g h risk, y o u m i g h t t h i n k twice 
before t r y i n g a vaccine for Alzheimer's 
disease or a t reatment that y o u have to 
take every day to w a r d i t off. So what 
we're t r y i n g to do is f i n d ways to inte-
grate genetic r isk i n f o r m a t i o n i n t o m a i n -
stream cl inical medic ine i n a way that's 
never been done before." 
Green is also involved i n A D A P T , 
w h i c h , he explains, takes the concept o f 
R E V E A L another step fur ther , e x a m i n -
i n g w h e t h e r nonstero idal a n t i - i n f l a m -
m a t o r y drugs ( N S A I D s ) can prevent or 
delay the onset o f A D . "We've been ta lk -
i n g a b o u t r i sk , b u t w h y are we t a l k i n g 
ahout r isk?" asks Green. " O n e o f the 
m o s t consistent ep idemiologica l clues 
has been an apparent protect ive effect o f 
N S A I D s . N o w we are f i n a l l y test ing this 
i n a prospective r a n d o m i z e d t r i a l . " 
To answer this quest ion , the N I A is 
f u n d i n g A D A P T , the w o r l d ' s largest p r i -
m a r y p r e v e n t i o n t r i a l for A D , for w h i c h 
B U S M is one o f six sites na t iona l ly and 
the o n l y site i n N e w England. Green and 
Sanford A u e r h a c h , M D , associate profes-
sor o f n e u r o l o g y and psychiatry, are co-
site directors o f the project . The study's 
a i m was to recrui t n o n d e m e n t e d p a r t i c i -
pants w h o are older t h a n 70 and have a 
first-degree relative w i t h A D . Participants 
are r a n d o m i z e d to receive an N S A I D 
(either n a p r o x y n or celecoxih) or a 
placebo, a n d t h e n examined annual ly 
f o r years to see w h e t h e r or n o t they 
develop A D . 
A D A P T has three missions, accord-
i n g to M a r y - T a r a R o t h , R N , M S N , M P H , 
a n d project manager for the study. The 
p r i m a r y miss ion is to evaluate the e f f i -
cacy o f the N S A I D s as c o m p a r e d to 
placebo for the p r e v e n t i o n o f A D . 
A n o t h e r is to de termine whether the 
N S A I D s can attenuate cognit ive decline 
w i t h aging, and the last is to compare 
the safety o f the treatments w i t h 
placebo. " B e y o n d those three objectives, 
we're also learn ing a l o t ahout h o w to 
conduct A D p r e v e n t i o n s t u d i e s — h o w to 
recru i t f o r t h e m , h o w to r u n t h e m , " she 
says. " T h a t is g o i n g to he very i m p o r -
tant , because n o t everyone w i l l he able 
to take N S A I D s or w i l l benef i t f r o m 
t h e m . So w e ' l l s tudy other treatments i n 
re la t ion to p r e v e n t i o n as w e l l . Learn ing 
h o w to r u n these studies is invaluable." 
As o f press t i m e , the treatments i n 
the A D A P T study had been suspended 
w h i l e safety issues concerning n a p r o x y n 
a n d celecoxih were reviewed. However , 
whether the treatments are c o n t i n u e d or 
p e r m a n e n t l y hal ted . Green believes 
Sanford Auerbach, MD (left), discusses 
cases involved in the ADAPT study with 
Mary-Tara Roth, RN, MSN, MPH, and Robert 
Green, MD. Auerbach and Green are co-site 
directors of the project, and Roth is project 
manager. 
A D A P T w i l l s t i l l y i e l d i m p o r t a n t i n f o r -
m a t i o n as par t ic ipants are f o l l o w e d for 
years to come. 
B U S M investigators are o p t i m i s t i c 
about f i n d i n g treatments f o r A D . 
Auerbach notes h o w researchers are 
focusing o n m a n y di f ferent aspects o f 
A D and most l ike ly w i l l come o u t w i t h 
treatments to benef i t patients at var ious 
stages o f the disease. " T h e r e is a cascade 
o f events that occur i n Alzhe imer ' s , lead-
i n g to cell death a n d loss o f f u n c t i o n , so 
the disease is p r o b a b l y treatable o n sev-
eral di f ferent levels," he says. " T h e key is 
we d o n ' t have to h i t a h o m e r u n — a c o u -
ple o f singles w o u l d do the t r i c k . " 
Green agrees. " D u r i n g the next five 
to 10 years, we're g o i n g to see t reatments 
emerging that s low progress ion, a n d tha t 
is where we ' l l make the m o s t progress," 
he says. "Remember, i f y o u c o u l d s i m p l y 
slow the rate o f decline b y 50 percent , or 
even hack u p the onset o f the disease b y 
five years, t h e n y o u c o u l d reduce the 
n u m b e r o f cases b y five to eight m i l l i o n . 
So s i m p l y delaying the onset o f the dis-
ease, as we hope to do i n the A D A P T 
study, c o u l d have huge p u b l i c heal th 
impl i ca t ions . " 
To learn more about BUMC research 
opportunities for Alzheimer's disease and 
its clinical services, you can contact the 
ADC via e-mail at huad@hu.edu, phone 
888-458-2823, or visit www.hualz 
research.org. 
To support ongoing Alzheimer's dis-
ease research, please consider making a 
tax-deductible donation payable to 
''Trustees of Boston University" and mail 
it to: Alzheimer's Disease Center, Boston 
University School of Medicine, 715 Alhany 
St., B-7800, Boston, MA 02118. • 
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Less than 10 years ago, the student 
body was mostly white males. 
Times have changed. 
Walk around the Boston University School of 
Medicine (BUSM) campus, and you'll see how 
diverse the student body has become in recent years. 
Men, women, people of different races, various eth-
nicities, young and middle-aged—the face of the 
BUSM student is more diverse than ever. In fact, this 
past fall's incoming class is the most diverse in the 
school's history. It consists of 55 percent women and 
18 percent minorities, one of the highest percent-
ages of minorities for medical schools nationwide. 
Students come from 21 countries other than the 
United States, and ages range from 20 to 45. 
BUSM admissions strives for a diverse student 
body, says Robert Witzburg, M D , associate dean and 
director of Admissions, professor of medicine at 
BUSM, and professor of health services at the 
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School o f Publ ic H e a l t h . H e says the school realizes that 
diversity is cr i t i ca l to today's m e d i c a l educat ion . "We need to 
graduate c u l t u r a l l y c o m p e t e n t physicians, a n d i t seems clear 
that the best way to develop c u l t u r a l competency is n o t 
t h r o u g h abstract reasoning, h u t t h r o u g h real- l i fe experience," 
he says. " I f t o m o r r o w ' s physicians are g o i n g to he able t o 
understand and value cul tures o ther t h a n the i r o w n , we have 
to give t h e m an o p p o r t u n i t y to g r o w w i t h that experience. We 
accept i t as o u r o b l i g a t i o n t o t r a i n physicians w h o can take 
care o f anybody." 
The benefits o f a diverse l i fe experience, as W i t z b u r g calls 
i t , are m u l t i f o l d . Such experience tends to break d o w n stereo-
types and biases, he says, and encourages students to t h i n k 
more creatively ahout the roles social a n d c u l t u r a l factors m a y 
play i n illness a n d heal th . " I t broadens the social a n d c u l t u r a l 
v i e w o f physicians i n the i r approach to c l in ica l practice, edu-
cat ion , and research," he says. 
A n u m b e r o f factors, i n c l u d i n g d e m o g r a p h i c trends, have 
c o n t r i b u t e d to BUSM's g r o w t h i n diversity, says W i t z b u r g . 
Nat ional ly , medica l school appl icat ions h a d d r o p p e d o f f b u t 
were b e g i n n i n g to increase again d u r i n g the past few years. 
B U S M is recovering somewhat faster t h a n the na t iona l n u m -
bers, says W i t z b u r g , and credits efforts by the school s tar t ing 
back i n 2002 t o connect w i t h heal th professional advisors and 
undergraduate i n s t i t u t i o n s a r o u n d the c o u n t r y . "We help 
t h e m see the benefi t o f a B U S M educat ion a n d encourage 
t h e m to t u r n the i r best students o n to o u r school," says 
W i t z b u r g . 
A n i m p o r t a n t d e m o g r a p h i c change has been the gender 
shift . B o t h na t iona l ly and at B U S M , the n u m b e r o f w o m e n 
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a p p l y i n g to medica l school has increased. A g a i n , B U S M has 
heen ahead o f the t r e n d , says W i t z h u r g , d r a w i n g m o r e w o m e n 
appl icants t h a n the n a t i o n a l average. I n p a r i , he believes this 
reflects the school's roots as the N e w E n g l a n d Eemale M e d i c a l 
College, w h i c h graduated the first female d o c t o r i n the n a t i o n . 
" I also t h i n k m a n y w o m e n are p a r t i c u l a r l y interested i n issues 
o f social justice. They're interested i n the h e l p i n g professions, 
i n the c o n n e c t i o n a m o n g science, society, and fami ly . Given 
o u r strengths i n the care o f vulnerable p o p u l a t i o n s and o u r 
c o m m i t m e n t to i n t e r n a t i o n a l health and social service, it's no 
surprise tha t w o m e n find B U S M an attractive place to t r a i n , " 
he says. 
O n e n a t i o n a l t r e n d B U S M is b u c k i n g is a steady eros ion 
i n m i n o r i t y a p p l i c a t i o n s t o m e d i c a l schools, notes W i t z h u r g . 
W i t z b u r g praises the efforts o f K e n n e t h E d e l i n , M l ) , associ-
ate dean f o r Students a n d M i n o r i t y A f f a i r s , professor o f 
ohstetr ics/gynecology, a n d the d i r e c t o r o f the E a r l y M e d i c a l 
School Selection P r o g r a m . Efe adds t h a t B U S M has w o r k e d 
to i m p r o v e the n u m b e r o f m i n o r i t y s tudents w h o c o m e f r o m 
the general a p p l i c a t i o n p o o l as w e l l . "We've w o r k e d v e r y 
h a r d t o make sure t h a t n a t i o n a l t r e n d is n o t ref lected i n o u r 
class," he says. 
Divers i ty is def ined i n m a n y ways, adds W i t z b u r g . "We 
l o o k f o r c u l t u r a l , l i n g u i s t i c , rac ia l , a n d e t h n i c d ivers i ty . 
We l o o k for divers i ty i n l i fe experience, b a c k g r o u n d , a n d age. 
We l o o k f o r divers i ty i n every d i m e n s i o n y o u can i m a g i n e , 
because we t h i n k that's w h a t creates a p r o d u c t i v e , exc i t ing 
educat ional e n v i r o n m e n t . " • 
On a Mission to 
omprehend 
gmory 
rt:^{^MiaMiiMamw|g|yTg^ 
his subjects—smart m i c e — w e r e the 
focus o f a D a v i d L e t t e r m a n t o p ten 
list ( "Top Ten Term Paper Topics 
VVril len b y Genius M i c e " ) , Joseph 
Tsien is easy to ta lk t o . Tsien, a P h D 
and neurobio logis t , came to Boston 
Univers i ty ( B U ) f r o m P r i n c e t o n 
Univers i ty this past s u m m e r to c o n -
t i n u e his research i n t o h o w m e m -
o r y is f o r m e d , processed, a n d 
stored. He became somewhat o f a 
celebrity i n the late '90s w h e n he 
genetically altered mice a n d created 
a mouse that n o t o n l y possessed 
enhanced m e m o r y , b u t intell igence 
as w e l l . 
A l t h o u g h m u c h o f the media 
hype s u r r o u n d i n g Tsien has sub-
sided, he has c o n t i n u e d steadily 
w i t h his research. H e was l u r e d to 
B U last s u m m e r by D a v i d Farb, 
P h D , professor o f p h a r m a c o l o g y 
a n d c h a i r m a n o f the D e p a r t m e n t o f 
Pharmacology at Boston Univers i ty 
School o f M e d i c i n e ( B U S M ) , to 
start a Center for Systems i n 
N e u r o b i o l o g y . I n this role , Tsien 
w i l l have a lab i n B U S M , as w e l l as 
i n the College o f Engineer ing o n 
BU's Charles River campus. I n 
a d d i t i o n to r u n n i n g the t w o labs, 
he ' l l be a professor at b o t h schools. 
I n Tsien's m i n d , b r i n g i n g together 
the t w o disciplines o f medica l 
research a n d engineer ing is w h a t he 
needs to p u s h his research to the 
next level. 
" I believe that science is i n this 
incredible t r a n s i t i o n p e r i o d f r o m t r a d i -
t i o n a l b io logy to m o r e o f a science o f 
i n f o r m a t i o n , " says Tsien. " T h a t is 
already witnessed b y the explos ion i n 
the a m o u n t o f data a n d i n f o r m a t i o n 
available, such as f r o m the g e n o m e 
project . H a v i n g t w o laborator ies w i l l 
give me the o p p o r t u n i t y to recrui t b o t h 
f r o m the m e d i c a l science o r i e n t e d 
students a n d the students w i t h eng i -
neer ing a n d mathemat ics b a c k g r o u n d s . 
I t h i n k tha t such a convergence o f m u l -
t i d i s c i p l i n a r y talents w i l l b r i n g a fresh 
energy i n t o this m o r e t r a d i t i o n a l 
neuroscience." 
A l t h o u g h his o u t l o o k is p ioneer -
i n g , Tsien's sc ient i f ic roots are steeped 
i n the t r a d i t i o n a l . H e f i rs t became 
interested i n h o w the b r a i n w o r k s as a 
college s tudent i n his h o m e l a n d o f 
C h i n a , w o r k i n g i n a lab a n d s t u d y i n g 
electrophysiology. " T h a t is w h e n y o u 
use electrodes t o measure b r a i n act iv-
i t y , " he explains. " T h i s was the early 
'80s, and the EEC e q u i p m e n t at the 
t i m e , w h i c h h a d a b o u t e ight channels, 
seemed sophist icated to m e c o m p a r e d 
to the e q u i p m e n t i n the c h e m i s t r y 
l a b — a bench t o p centr i fuge t h a t m o v e d 
f r o m one end o f the b e n c h to the o t l i e r 
w h e n i t s p u n . A n d w h e n I got i n the 
lab, the f i rs t t i m e I heard a n e u r o n 
s p a r k i n g — y o u k n o w , they f i re , a n d y o u 
can hear that , l i t e r a l l y — I got excited." 
A t the end o f his senior year o f co l -
lege, Tsien decided to c o n t i n u e his s t u d -
ies. H e w a n t e d to unders tand the 
molecular basis o f n e u r o n a c t i o n . 
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" I realized at the t i m e that a l t h o u g h we 
can measure the neura l act ivi ty , we d o n ' t 
k n o w even the very basic questions l ike 
what is the molecular basis b y w h i c h the 
action potent ia l is generated—the n e u -
rons get charged, a n d they spike, w h i c h 
is called act ion potent ia l . H o w does a 
neuron generate signals?" he says. 
To f i n d his answers, Tsien left 
China , travel ing to the U n i t e d States and 
the Univers i ty o f M i n n e s o t a where he 
j o i n e d the D e p a r t m e n t o f M o l e c u l a r 
Biology and Biochemistry. H e earned his 
P h D under the tutelage o f Lester 
Drewes, PhD, c o n d u c t i n g exper iments 
o n the neurotransmit ter system acetyl-
choline, w h i c h is essential f o r certain 
b r a i n funct ions . T h e y examined , for 
example, h o w chemical warfare agents 
l ike sarin i n h i b i t acetylcholine's s ignal-
i n g pathway. 
F r o m there Tsien w e n t to C o l u m b i a 
Univers i ty where he w o r k e d as a post-
doctora l associate f r o m 1990 to 1993 i n 
the lab o f Eric Kandel , P h D , w i n n e r o f 
the 2000 N o b e l Prize i n Physiology or 
Medic ine . " T h a t was the f i rs t t i m e 1 
began to w o r k o n the b r a i n and m e m -
ory. A t the t i m e , m y interest was to t r y 
to ident i fy what are the genetic p r o -
grams that c o n t r o l the b r a i n act ivi ty ," 
said Tsien. 
He next went to M I T as a senior 
research associate a n d j o i n e d the lab o f 
Susumu Tonegawa, P h D , w h o also w o n 
the Nobe l Prize i n Physiology or 
Medic ine i n 1987. There Tsien devel-
oped a new technique f o r s t u d y i n g 
genetic funct ions . H e was specifically 
interested i n the N M D A ( N - m e t h y l - D -
aspartate) receptor a n d its role i n learn-
i n g and m e m o r y . A c c o r d i n g to Tsien, 
scientists theor ized that the N M D A 
receptor was involved i n regulat ing the 
way neurons c o m m u n i c a t e w i t h each 
other : I t helps strengthen the connect ion 
between t w o neurons that are s i m u l t a -
neously active, and they believed this 
s trengthening was the basis for learning 
and memory (known as Hebb's t h e o r y ) . 
A t the t i m e , researchers were s tudy-
i n g genetics us ing w h a t was called a 
f i rs t -generat ion k n o c k o u t technique: 
T h e y w o u l d disable a gene f r o m a mouse 
e m b r y o and t h e n see h o w the mouse 
developed, l o o k i n g for abnormal i t ies . 
The technology, however, d i d n ' t transfer 
w e l l to the neurosciences, says Tsien. The 
genes involved w i t h the N M D A recep-
tors t u r n e d o u t to be essential for 
healthy development , and the mice o f ten 
died as pups . "Also, i f y o u are interested 
i n the behavior o f the mouse, y o u d o n ' t 
w a n t to k n o c k o u t a gene that plays an 
i m p o r t a n t role d u r i n g development , 
because that c o u l d complicate y o u r 
in terpre ta t ion , " he explains. 
Tsien and his colleagues 
took an educated guess as to 
which part of the memory to 
enhance. Their experiments 
worked even better than they 
expected: The genetically 
altered mice exhibited not 
only enhanced memory but 
greater learning abilities, too. 
To solve his p r o b l e m , Tsien devel-
oped a second-generation technique that 
a l lowed h i m to k n o c k o u t a par t o f the 
N M D A receptor involved i n the f o r m a -
t i o n o f m e m o r y called the N R l s u b u n i t 
located i n a specific region o f the h i p -
pocampus. " T h e technique is called c o n -
d i t i o n a l k n o c k o u t , " he says, " a n d i t 
a l lowed me to k n o c k o u t the genes i n 
that specific region o f the b r a i n . Also , 
the k n o c k o u t d i d n ' t occur u n t i l after 
development . I t t o o k me about three 
years to develop, a n d i t n o w has become 
a w i d e l y used technique." 
The resul t ing k n o c k o u t mice exhib-
i ted p r o f o u n d m e m o r y deficits, says 
Tsien, p r o v i d i n g i n i t i a l evidence o f the 
role o f the N M D A receptor as a m e m o r y 
swi tch . " T h e y c o u l d n o t remember 
t h i n g s — s p a t i a l m e m o r y , for e x a m p l e — 
and they also h a d p o o r nonspat ia l m e m -
ory, such as r e c o g n i t i o n m e m o r y , " he 
says. 
A l t h o u g h these experiments sup-
p o r t e d the hypothesis that the N M D A 
receptors are c r i t i ca l f o r m e m o r y , they 
weren' t conclusive. O t h e r factors n o t 
a t t r ibutable to the N R l c o u l d have 
resulted i n the i m p a i r m e n t s . 
A r o u n d this t i m e , Tsien decided he 
was ready to lead his o w n g r o u p o f 
researchers. So i n 1997, he m o v e d to 
Pr ince ton Univers i ty , b e c o m i n g an assis-
tant professor i n the D e p a r t m e n t o f 
M o l e c u l a r B i o l o g y a n d sett ing u p his 
o w n lab. I t was here that he devised his 
next exper iment : a w a y to genetically 
enhance m e m o r y i n mice by increasing 
the f u n c t i o n o f the N M D A receptor. I f 
the results enhanced m e m o r y , they 
w o u l d p r o v i d e f u r t h e r p r o o f that the 
N M D A receptor plays a key role i n 
m e m o r y processes. 
A c c o r d i n g to Tsien, he and his col -
leagues t o o k an educated guess as to 
w h i c h p a r t o f the N M D A receptor to 
enhance, basing i t o n knowledge o f h o w 
t w o subuni ts ( N R 2 B a n d N R 2 A ) per-
f o r m i n y o u n g versus a d u l t mice. The i r 
experiments w o r k e d even better than 
they expected: The genetically altered 
mice exhib i ted n o t o n l y enhanced m e m -
o r y b u t greater l e a r n i n g ab i l i ty as wel l . 
The w o r l d t o o k not ice , and specula-
t i o n , a long w i t h controversy, arose about 
us ing the technology to enhance h u m a n 
intell igence. A c c o r d i n g to Tsien, h o w -
ever, that wasn't the p o i n t . " I wasn't t r y -
i n g to create a smart mouse," he says. " I 
was t r y i n g to create a m o r e str ingent test 
for this hypothesis , that the N M D A 
receptor is a molecular swi tch for m e m -
ory, and I t h i n k the exper iment p r o -
v i d e d g o o d evidence s u p p o r t i n g the 
H e b b theory. T h a t is very i m p o r t a n t . 
Remember, there are n o t m a n y theories 
available f o r g u i d i n g o u r research, so i t 
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was a useful exper iment . Also, i t p o t e n -
t i a l l y p r o v i d e d a d r u g target for 
researchers deal ing w i t h m e m o r y disor-
ders l ike Alzheimer ' s . But any t rans la t ion 
f r o m a d r u g target to an F D A - a p p r o v e d 
d r u g , i f i t w o r k s i n the end, usually takes 
a decade." 
I n the wake o f al l the media hype, 
Tsien pushed f o r w a r d w i t h his research. 
The m e m o r y process is a mult istage 
p h e n o m e n o n — a c q u i s i t i o n , consol ida-
t i o n , storage, and r e t r i e v a l — a n d Tsien 
n o w w a n t e d to unders tand the m o l e c u -
lar basis o f each i n d i v i d u a l stage. To do 
th i s , he needed t o develop a t h i r d -
generat ion k n o c k o u t technique. "You 
w a n t to have the capabi l i ty to i n d u c i b l y 
k n o c k o u t o n l y a certain stage o f the 
m e m o r y process. For example , y o u 
selectively i m p a i r the c o n s o l i d a t i o n 
stage," he expla ins . " I n the second-
generat ion k n o c k o u t , at a certain stage i n 
the mouse's development the k n o c k o u t 
happens, and then it's constantly there. 
I n the t h i r d generation we can k n o c k o u t 
just before a certain e x p e r i m e n t — w e can 
t u r n the gene o n and off." 
U s i n g this technique, Tsien discov-
ered that the N M D A receptor is involved 
i n the conso l ida t ion phase o f m e m o r y : 
By s w i t c h i n g the N M D A receptor o n 
and o f f d u r i n g the conso l ida t ion p e r i o d , 
they f o u n d tha t m e m o r y conso l idat ion 
depends o n the react ivat ion o f the 
N M D A receptor. T h a t is essential for 
consol idat ing s h o r t - t e r m m e m o r y i n t o 
l o n g - t e r m m e m o r y , he says. The b r a i n 
also stores—or reconso l idates—memo-
ries, says Tsien, and they f o u n d that the 
N M D A receptor plays a par t i n this 
process as w e l l . 
F r o m there, his lab began w o r k o n 
a f o u r t h - g e n e r a t i o n technique called the 
i n d u c i b l e p r o t e i n k n o c k o u t , w h i c h , as 
the name indicates, knocks o u t a p r o t e i n 
instead o f a gene. " W h e n y o u k n o c k o u t 
What does a memory look 
like? Can it be expressed in 
mathematical terms? Can it 
be described? Those are some 
of the fundamental questions 
that Tsien wants to answer. 
a gene, the proteins have already been 
made, so y o u have to w a i t for t h e m to 
degrade before y o u can see the effect. 
A n d degradat ion is a slow process. You 
have to w a i t for several days," says Tsien. 
The i n d u c i b l e p r o t e i n k n o c k o u t is 
m o r e r a p i d . A l t h o u g h i t t o o k his lab 
f o u r years to develop the technique, the 
payof f was w o r t h the ef for t : By k n o c k i n g 
o u t the p r o t e i n direct ly, Tsien says he 
can c o n t r o l the molecular ac t iv i ty w i t h i n 
minutes . " I t al lows us to s tudy a l o t o f 
b io log ica l processes that require a fast 
Tsien is currently working on a technique 
that can monitor the brain activity of more 
than 100 neurons. Now he needs to deter-
mine the best ways to analyze the massive 
amounts of data he has collected. 
t i m e reso lut ion , such as the s h o r t - t e r m 
m e m o r y process a n d m e m o r y retr ieval , " 
he says. 
A c c o r d i n g to Tsien, his lab c o n t i n -
ues to develop such techniques. N o w , 
however, they w i l l do so at B U . 
Current ly , they are w o r k i n g o n a tech-
nique that can m o n i t o r the b r a i n act iv-
i t y o f m o r e t h a n 100 neurons . 
" T r a d i t i o n a l l y , y o u s tudy one o r t w o 
neurons," says Tsien. " B u t the b r a i n f u n -
damenta l ly operates w i t h a large n u m -
ber o f neurons s imultaneously . So t h e n 
i t becomes obvious tha t the way y o u t r y 
to unders tand h o w the b r a i n w o r k s is to 
m o n i t o r the ac t iv i ty o f a large n u m b e r 
o f neurons." 
Tsien has already spent a b o u t three 
years deve loping this technique , a n d 
they've been able to record u p to several 
h u n d r e d neurons i n a freely behaving 
mouse. The p r o b l e m he n o w faces is 
h o w to analyze the t r e m e n d o u s a m o u n t 
o f data he's captured: Just 30 m i n u t e s o f 
recording results i n a b o u t 5 0 0 M B o f 
i n f o r m a t i o n . " Y o u need engineers a n d 
mathemat ic ians a n d c o m p u t e r scien-
tists," says Tsien. "That 's w h y it's so 
attractive to me to have th is o p p o r t u n i t y 
to b r i n g people f r o m di f ferent d isc i -
plines together to tackle this very i m p o r -
tant quest ion o f h o w m e m o r y 
per forms . " 
W h a t does a m e m o r y l o o k like? 
Can i t be expressed i n m a t h e m a t i c a l 
terms? Can i t be described? Those are 
some of the f u n d a m e n t a l questions that 
Tsien wants to answer. "We k n o w m o r e 
about w h a t happens at the molecu lar 
level, inside the n e u r o n , " he says, " b u t 
the challenge w i l l be to t r y to u n d e r -
stand h o w neurons c o m m u n i c a t e and 
h o w they come together to f o r m a m e m -
ory. We d o n ' t even k n o w w h a t a m e m -
o r y is. Answering these questions 
represents a t r e m e n d o u s o p p o r t u n i t y for 
neurobio logy. " • 
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Driven by a desire to 
know "why," these CMS 
students have taken to 
the lab to learn about 
medical science. 
Medicine and research go hand in hand, 
as any student in the Division of 
Graduate Medical Sciences (CMS) at 
Boston University School of Medicine 
(BUSM) can tell you. Without research, 
medicine would not advance. As such, 
students earning their PhDs spend the 
majority of their time in labs, learning 
how to explore and use medical litera-
ture, conduct experiments, and interpret 
the results. The following four students 
exemplify the tremendous talents being 
cultivated in the CMS. 
Generation 
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of Researchers 
R E B E C C A S A E F 
Choosing the M D / P h D p r o g r a m s i m p l y 
made sense to Rebecca Saff. A l t h o u g h 
she enjoyed research, she w a n t e d her 
w o r k to have m o r e o f a pat ient and dis-
ease basis. "The idea o f an M D / P h D is 
that y o u can translate medic ine f r o m the 
bench to the bedside," says Saff. " I t gives 
y o u the ab i l i ty to use w h a t y o u learn 
about y o u r patients a n d the trends y o u 
see i n the c l inic , and t h e n see w h a t they 
m i g h t mean o n a basic science level. 
Using genetics or i m m u n o l o g y , h o w 
does i t all fit together? A n d t h e n y o u 
take w h a t y o u learn back i n t o medic ine . " 
N o w i n her t h i r d year o f medica l 
school, Saff already has finished her 
PhD. She specialized i n oncobiology, 
w o r k i n g i n the lab o f A n n Marshak-
Rothstein, PhD, professor o f m i c r o b i o l -
ogy, pathology and laboratory medic ine , 
and environmenta l health. Saff w o r k e d 
o n t w o projects. I n one, she s tudied m o l -
ecules—Fas and Fas l i g a n d — t h a t are 
involved i n act ivat ion i n d u c e d cell death. 
N o r m a l l y , Fas and Fas l igand help y o u r 
b o d y clear T cells at the end o f an 
i m m u n e response. But i n the case o f 
cancer, says Saff, y o u w a n t the T cells to 
survive and cont inue fighting the t u m o r . 
I f y o u can prevent the Fas a n d Fas l i g a n d 
f r o m being upregulated, y o u can increase 
the survival o f T cells and the i r efficacy 
at k i l l i n g t u m o r cells. "Part o f m y project 
was to take T cells that lack Fas or Fas 
l igand and inject t h e m i n t o mice w i t h 
t u m o r s and then l o o k at the response," 
she says. " I t actually showed that i f T 
cells survive longer, they are m u c h better 
at k i l l i n g the t u m o r i n mice." 
Saff entered her research i n Boston 
University's ( B U ) Science & Technology 
Day 2004 and w o n the prestigious 
President's A w a r d . The day featured 
m o r e t h a n 160 presentations by B U 
graduate students across al l disciplines 
and schools. 
f i e r other project also revolved 
a r o u n d Fas l igand , b u t i n this case, Saff 
l o o k e d at its ab i l i ty to induce i n f l a m m a -
t i o n under certain circumstances. " I f 
y o u can induce enough i n f l a m m a t i o n , 
y o u can actually k i l l a t u m o r , " she says. 
"So I s tudied w h a t cells mediate the 
re ject ion process by expressing Fas l i g -
and i n a t u m o r cell l ine , in jec t ing those 
cells i n t o mice , and f o l l o w i n g the 
i n f l a m m a t o r y response that occurs." 
I t wasn't just the i n f l a m m a t i o n , 
notes Saff, b u t a certain phase o f 
response that was needed to get the 
t u m o r re ject ion. The project was suc-
cessful, she says, and the mice were p r o -
tected f r o m the t u m o r l ine . 
N o w Saff is back i n medica l school, 
p e r f o r m i n g her var ious clerkships. Soon, 
however, she'll be t a k i n g some t i m e off . 
Saff is expecting her second c h i l d this 
winter . She actually had her first son, 
F t h a n , w h i l e earning her doctorate. " M y 
last year o f m y doctorate I d i d a l o t o f 
j u g g l i n g w i t h m y husband," she says. 
" N o w I ' m go ing to spli t m y t h i r d year o f 
medica l school i n t o t w o years so I can 
spend t i m e w i t h m y ch i ldren . " 
Once she's completed her M D , Saff 
wants to do b o t h research and c l inical 
w o r k . She realizes, however, that this 
m a y be d i f f i c u l t w h i l e her c h i l d r e n are 
y o u n g . She has even bigger aspirations 
for the f u t u r e . " W h a t I w o u l d love to do 
i n the l o n g t e r m is be the dean o f a 
medica l school ," she says. " I was the 
chair o f S C O M S A [Student C o m m i t t e e 
o n M e d i c a l School A f f a i r s ] , and vice 
chair, a n d I ' m s t i l l involved w i t h that , 
a n d I ' m o n the c l in ica l c u r r i c u l u m c o m -
mit tee . I really enjoy the pace o f aca-
demics, a n d I t h i n k the dean needs a 
s t rong b a c k g r o u n d i n b o t h research and 
medic ine , as w e l l as a d m i n i s t r a t i o n . So 
i n the l o n g r u n , I w o u l d love to do that ." 
C h r i s t i n a M o r k grew u p w i t h a g r a n d -
m o t h e r w h o h a d m u l t i p l e sclerosis, 
w h i c h she says sparked her interest i n 
research. " I d i d n ' t w a n t to be a doctor , 
b u t 1 w a n t e d to do s o m e t h i n g that 
w o u l d help people," she says. 
Instead o f s t u d y i n g medic ine , M o r k 
is earning her P h D i n the M i c r o b i o l o g y 
D e p a r t m e n t as p a r t o f Douglas Faller's 
lab. Faller, M D , P h D , is a professor o f 
medic ine , pediatr ics , b iochemis t ry , 
m i c r o b i o l o g y , and p a t h o l o g y a n d labo-
r a t o r y medic ine , G r u n e b a u m Professor 
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i n Cancer Research, and direc tor o f the 
Cancer Research Center. 
As p a r t o f her research, M o r k is 
s t u d y i n g b u t y r i c ac id, an H D A C (his-
tone deacetylase) i n h i b i t o r that causes 
cancer cells to stop g r o w i n g o u t o f c o n -
t r o l . She's t r y i n g to de termine h o w the 
d r u g w o r k s . 
Researchers k n o w at w h i c h p o i n t i n 
the cell cycle the d r u g stops the cells 
f r o m g r o w i n g , says M o r k , and they also 
k n o w some o f the prote ins that are 
i n v o l v e d i n the process. " T h e f irst step i n 
f i n d i n g the m e c h a n i s m is to f i n d all the 
players, a l l the proteins involved, and 
that's w h a t I 've been w o r k i n g o n so far," 
she says. " T h e way y o u f igure this o u t is 
y o u take each p r o t e i n o u t o f the c e l l — 
y o u k n o c k i t o u t i n a few di f ferent 
w a y s — a n d t h e n see i f the d r u g s t i l l stops 
the cell f r o m g r o w i n g . " 
N o w i n her f o u r t h year o f school , 
M o r k k n o w s she most l ike ly has another 
year a n d a h a l f o f research to go, b u t she 
enjoys w o r k i n g i n the lab. Last year, 
w h i l e s t i l l w o r k i n g o n her P h D , she 
shared some o f her enthusiasm for sci-
ence w i t h students at Q u i n c y H i g h 
School outside o f Boston via a N a t i o n a l 
Science F o u n d a t i o n fe l lowship . " I helped 
o u t i n the h o n o r s a n d A P b i o l o g y 
classes," she says. " I t was f u n . I was m o r e 
o f a lab assistant, w h i c h I t h i n k m y 
teacher f o u n d h e l p f u l , because it's t o u g h 
to r u n a lab. There are so m a n y kids a n d 
just one teacher. To help t h e m learn h o w 
to use a microscope, the teacher can't get 
a r o u n d to every person." 
Fven t h o u g h M o r k enjoyed her 
experience i n the classroom, she's leaning 
m o r e t o w a r d t a k i n g a j o b i n i n d u s t r y — 
perhaps for a pharmaceut ical c o m -
p a n y — r a t h e r t h a n academia, once she's 
f in ished her P h D . The idea o f research-
i n g drugs that c o u l d someday help peo-
ple appeals to her. " T h e h u m a n aspect o f 
research intr igues me," she says. 
A N D Y F E R G U S O N 
O n e summer , as a b i o l -
ogy undergraduate at 
Wake Forest U n i v e r s i t y 
i n N o r t h Caro l ina , A n d y 
Ferguson par t i c ipated i n 
the N a t i o n a l Science 
Foundat ion 's Research 
Fxperiences f o r 
Undergraduates p r o -
g r a m . H e w o r k e d i n a 
lab at the U n i v e r s i t y o f 
F l o r i d a c l o n i n g c a l c i u m |^. A i w * 
channel , l o o k i n g at i t i n 
re la t ion to a parasitic 
disease. 
" I was s i t t ing i n 
the lab one n i g h t — t h e y 
d i d n ' t force y o u to be there. I was there 
o f m y o w n w i l l . I w a n t e d to set u p this 
react ion so I c o u l d f i n d o u t the answer 
the next day. I could 've wai ted u n t i l the 
next day to do the exper iment , b u t then 
I w o u l d ' v e had to w a i t another day to 
get the results," says Ferguson. " I h a d 
that m o t i v a t i o n a n d desire to t r y to 
unders tand w h a t was g o i n g o n , a n d I 
w a n t e d to do i t t h e n . So that's w h e n I 
realized that I really l ike th is a n d 
t h o u g h t I c o u l d pursue i t . " 
N o w i n his f i f t h year o f s c h o o l , 
Ferguson is close to c o m p l e t i n g his P h D 
as p a r t o f the C M S I m m u n o l o g y 
T r a i n i n g P r o g r a m , w o r k i n g i n the lab o f 
Ronald Corley, P h D , professor o f m i c r o -
b i o l o g y and c h a i r m a n o f the M i c r o b i o l -
ogy D e p a r t m e n t . The focus o f Ferguson's 
research is B cells, specifically, the role o f 
the a n t i b o d y I g M ( I m m u n o - g l o b u l i n 
M ) a n d its a b i l i t y to enhance the 
i m m u n e response. 
As p a r t o f his research, Ferguson 
in jected mice w i t h an I g M i m m u n e 
c o m p l e x to d e t e r m i n e w h e r e i t l o c a l -
ized. " F o r the f i r s t c o u p l e o f years I saw 
i t loca l ized i n a special cel l i n the 
spleen, a n d I was ask ing h o w does i t 
get there a n d w h a t c o n d i t i o n s are nec-
essary f o r i t to get there . N o w I ' m t r y -
i n g t o answer w h y it 's g e t t i n g there , 
a n d w h a t relevance does i t have," says 
Ferguson. " I have some ideas tha t we 
are c u r r e n t l y tes t ing . " 
Ferguson m a y n o t have his answers 
yet, b u t his research has already 
impressed his professors. He w o n the 
C o r w i n A w a r d , w h i c h is given by the 
D e p a r t m e n t o f M i c r o b i o l o g y i n recogni -
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t i o n o f exemplary scholarly or scientific 
achievement, values o f coUegiality, a n d 
scientific integr i ty . H e also w o n second 
prize o n Russek Day, an awards p r o g r a m 
administered by the C M S D i v i s i o n that 
recognizes accomplishments a n d c o m -
m i t m e n t to the p u r s u i t o f research i n 
basic sciences. 
However, for Ferguson, the best 
reward w i l l be f i n i s h i n g his degree. 
W h e n that happens, he's cons ider ing a 
career i n academia as a pos tdoctora l 
candidate. " I t h i n k w o r k i n g at a place 
like a medical school w o u l d be an ideal 
setting. You're d o i n g research, b u t y o u r 
teaching responsibilit ies are somewhat 
l i m i t e d , " he says. 
W h i l e he enjoyed his t i m e as a 
teaching assistant i n the m i c r o b i o l o g y 
lab, Ferguson favors lab w o r k . " I enjoy 
discussing things w i t h people , l e a r n i n g 
f r o m t h e m , a n d t h e m l e a r n i n g f r o m 
me," he says. " B u t I ' d rather be i n the 
lab. I just get m o r e e n j o y m e n t o u t o f 
the experience." 
D A M I E N S L A T E R 
D a m i e n Slater already has w o r k e d i n the 
research i n d u s t r y . A f t e r earning his 
undergraduate degree i n m i c r o b i o l o g y 
f r o m the Univers i ty o f N e w H a m p s h i r e , 
he t o o k a j o b i n an immunogenet i cs lab-
oratory , where he s tudied a u t o i m m u -
ni ty , genetics, and h o w antibodies are 
p r o d u c e d . F r o m there, he w e n t to 
another lab at a biotech company, where 
he focused o n pathology. " T h e y o r i g i -
nated as a tissue bank," says Slater, " b u t 
w a n t e d to become m o r e involved w i t h 
genomics research and p r o v i d e m i c r o a r -
rays. That 's a gene c h i p tha t a l lows 
y o u t o l o o k at w h a t genes are b e i n g 
expressed i n a cell, and y o u can l o o k at 
10,000 genes at the same t i m e . That's the 
way a l o t o f biotech research is going . " 
A l t h o u g h fascinated by the w o r k , 
Slater realized he w o u l d n o t get a chance 
to help lead that research w i t h o u t his 
P h D . So he came to the C M S and j o i n e d 
the Genetics a n d Genomics p r o g r a m , 
w o r k i n g i n the lab o f Cyrus V a z i r i , P h D , 
assistant professor o f medic ine , p a t h o l -
ogy and l a b o r a t o r y m e d i c i n e , a n d genet-
ics a n d genomics . 
Slater's research involves D N A rep l i -
cation and its potent ial applicat ion to 
cancer. "We're l o o k i n g at h o w a cell m a i n -
tains contro l over replication so that i t 
can fa i th fu l ly replicate all o f its D N A i n 
one cell cycle b u t not re-replicate any 
regions o f D N A , " explains Slater. 
H i s lab is t r y i n g to l i n k the deregu-
l a t i o n o f i n i t i a t i o n factors for D N A 
repl i ca t ion to a p h e n o m e n o n called gene 
a m p l i f i c a t i o n . There are a n u m b e r o f 
cancers i n w h i c h the progression o f 
t u m o r s has been associated w i t h a m p l i -
f i ca t ion o f p a r t i c u l a r genes that play 
i m p o r t a n t roles i n cell cycle progression, 
says Slater. The precise mechanism o f 
h o w gene a m p l i f i c a t i o n arises is p o o r l y 
u n d e r s t o o d . "We're l o o k i n g at h o w the 
cell controls this , " he says. 
"It 's a very f u n d a m e n t a l process," 
says Slater, " a n d I t h i n k that's one o f the 
reasons I ' m at tracted to the research. It's 
s o m e t h i n g that bacteria are us ing, yeast 
are using. D N A repl i ca t ion is one o f the 
f u n d a m e n t a l or ig ins o f l i fe . I t h i n k that's 
w h y I was interested i n this l ine o f 
research, too . I l ike the b i g p ic ture . I l ike 
to t h i n k a b o u t e v o l u t i o n a n d h o w things 
came to be." 
W i t h m o r e t h a n three years o f his 
P h D b e h i n d h i m . Slater st i l l th inks he 
has several m o r e years o f w o r k to go 
before he ' l l f i n i s h . " I t h o u g h t I w o u l d be 
able to f i n i s h q u i c k l y since I ' m a l i t t le 
older a n d was really i n t e n t o n get t ing 
m y research done," he says. " B u t m y g i r l -
f r i e n d and I h a d t w i n s at the end o f m y 
f irst year. I t has been really amazing." 
H a v i n g a f a m i l y may also influence 
Slater's career decisions. A l t h o u g h he's 
leaning t o w a r d academia, he's n o t sure i f 
he can devote the a m o u n t o f t i m e 
needed d u r i n g a postdoctora l a p p o i n t -
m e n t . "1 really l ike the academic env i -
r o n m e n t , b u t h a v i n g a fami ly , certain 
th ings become i m p o r t a n t , " he says. " I ' m 
s t i l l n o t sure." • 
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R u b e n Azocar , M D , assistant professor 
o f anesthesiology at Boston Univers i ty 
School o f M e d i c i n e ( B U S M ) a n d an 
anesthesiologist at Boston M e d i c a l 
Center ( B M C ) , has received the 2004 
Anesthesiology Teaching Recogni t ion 
A w a r d , H o n o r a b l e M e n t i o n , f r o m the 
I n t e r n a t i o n a l Anesthesia Research 
Society. The award recognizes Azocar f o r 
his " superb teaching ab i l i ty a n d extraor-
d i n a r y c o n t r i b u t i o n s to educat ion i n 
anesthesiology." 
R i c h a r d B a b a y a n , M D , professor o f 
u r o l o g y a n d c h a i r m a n o f the D e p a r t -
m e n t o f U r o l o g y at B U S M , a n d chief 
o f U r o l o g y at B M C , has been elected to 
the b o a r d o f directors o f the A m e r i c a n 
U r o l o g i c a l Associat ion ( A U A ) . Babayan 
w i l l represent the AUA's N e w England 
Section. 
C h e r y l Barbanel , M D , M B A , M P H , 
B U S M associate professor o f medic ine 
a n d c h i e f o f O c c u p a t i o n a l a n d 
E n v i r o n m e n t a l M e d i c i n e at B o s t o n 
U n i v e r s i t y M e d i c a l Center ( B U M C ) , 
is the n e w pres ident -e lec t o f the 
A m e r i c a n College of Occupational and 
E n v i r o n m e n t a l M e d i c i n e ( A C O E M ) , an 
i n t e r n a t i o n a l medica l society o f m o r e 
t h a n 6,000 occupat iona l and e n v i r o n -
m e n t a l medic ine physicians and al l ied 
health professionals. She w i l l assume the 
presidency i n May. 
James Becker, M D , James U t l e y 
Professor, c h a i r m a n o f the D e p a r t m e n t 
o f Surgery at B U S M , a n d s u r g e o n - i n -
chief at B M C , was n a m e d H u m a n i t a r i a n 
o f the Year b y the N e w England Chapter 
o f the Crohn's a n d Col i t i s F o u n d a t i o n o f 
A m e r i c a . H e is the first surgeon to ever 
be accorded this h o n o r . 
To celebrate the c o n s t r u c t i o n o f the 
t h i r d B i o S q u a r e b u i l d i n g at 670 A l b a n y 
Street, Boston M a y o r T h o m a s M e n i n o 
j o i n e d T h o m a s M o o r e , M D , act ing 
provost , B U M C , Elaine U l l i a n , B M C 
president and C F O , a n d other officials 
f o r a t o p p i n g - o f f ceremony. M e n i n o 
congratulated B U M C , n o t i n g h o w 
BioSquare, a 14-acre b i o m e d i c a l 
research park , w i l l s trengthen Boston's 
g r o w i n g r e p u t a t i o n as an i n n o v a t o r i n 
l i fe sciences. The eight-story, 160,000-
square-foot l a b o r a t o r y is scheduled to 
be comple ted b y October 2005. 
Boston U n i v e r s i t y ( B U ) President ad 
interim A r a m C h o b a n i a n , M D , a n d 
Boston M a y o r T h o m a s M e n i n o 
a n n o u n c e d that B U w i l l f u n d a $ 1 m i l -
l i o n j o b - t r a i n i n g i n i t i a t i v e p r o v i d i n g 
b i o m e d i c a l research a n d b i o t e c h n o l o g y 
j o b t r a i n i n g to 105 B o s t o n residents. 
Th i s B U j o b - t r a i n i n g p r o g r a m w i l l p r e -
pare Boston residents f o r some o f the 
o p p o r t u n i t i e s created b y n e w l a b o r a t o -
ries be ing b u i l t o n the m e d i c a l campus , 
i n c l u d i n g the Biosafety Faboratory , as 
w e l l as i n the g r o w i n g b i o t e c h i n d u s t r y 
i n Boston. The i n i t i a t i v e is a m a j o r 
expansion o f B U M C ' s C i t y L a b 
Academy, a n i n e - m o n t h p r o g r a m that 
prepares students w h o have a h i g h 
school d i p l o m a or G F D f o r an e n t r y -
level j o b i n a b i o m e d i c a l l abora tory . 
CityLab Academy is also a partner i n a 
newly awarded $1.3 m i l l i o n grant f r o m 
the U.S. D e p a r t m e n t o f Fabor. The 
Massachusetts Biotechnology Educat ion 
F o u n d a t i o n , o f w h i c h the CityFab p r o -
g r a m is a partner, was awarded the grant 
as par t o f the President's H i g h G r o w t h 
Job Tra in ing Init iat ive. T h r o u g h the i n i -
tiative, BioCareer Fabs w i l l be launched i n 
25 u r b a n and high-needs publ ic schools. 
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Douglas Faller, M D , P h D , B U S M p r o -
fessor o f medic ine , pediatr ics , b i o c h e m -
istry, microb io logy , and p a t h o l o g y a n d 
laboratory medic ine , a n d direc tor o f 
the Cancer Research Center, has been 
n a m e d the first recipient o f the K a r i n 
G r u n e b a u m Cancer Research Profes-
sorship. Faller graduated f r o m H a r v a r d 
Medica l School and comple ted his resi-
dency i n i n t e r n a l m e d i c i n e at the 
Univers i ty o f Ca l i forn ia , San Francisco. 
He received a P h D i n cancer b i o l o g y a n d 
cancer v i r o l o g y f r o m the Massachusetts 
Inst i tute o f Technology. Before j o i n i n g 
B U M C i n 1991, he served o n the facul ty 
at H a r v a r d Medica l School, B r i g h a m 
and Women's H o s p i t a l , C h i l d r e n ' s 
Hospi ta l , and the Dana Farber Cancer 
Inst i tute . Faller has received n u m e r o u s 
awards and honors for his research a n d 
has p u b l i s h e d m o r e t h a n 300 peer-
reviewed articles i n the m e d i c a l a n d 
scientif ic l i terature . 
I n 2002, the trustees o f the K a r i n 
G r u n e b a u m Cancer Research F o u n -
d a t i o n c o n t r i b u t e d $2 m i l l i o n t o 
e n d o w the K a r i n G r u n e b a u m Profes-
sorship i n Cancer Research at B U S M . 
F r i t z G r u n e b a u m , w h o d i e d i n 1992, 
established the f o u n d a t i o n i n m e m o r y 
o f his first w i f e , K a r i n , w h o d i e d o f 
cancer i n 1958. T h r o u g h o u t the years, 
the f o u n d a t i o n also has p r o v i d e d f e l -
l o w s h i p s t o B U S M f o r st ipends t o s t u -
dents i n v o l v e d i n cancer research. 
l a m e s F e l d m a n , M D , B U S M associate 
professor o f emergency m e d i c i n e a n d 
a phys ic ian i n B M C ' s Emergency 
D e p a r t m e n t , received the State A w a r d 
f o r Excellence f r o m the A m e r i c a n 
Academy o f Nurse Pract i t ioners for his 
c o n t r i b u t i o n s t o hea l th care de l ivery 
a n d advocacy o n b e h a l f o f nurse 
p r a c t i t i o n e r s . 
D a v i d Felson, M D , B U S M chief o f c l i n i -
cal epidemiology, was awarded the Lee 
C. H o w l e y Sr. Prize for Research i n 
A r t h r i t i s f r o m the A r t h r i t i s F o u n d a t i o n . 
Felson was h o n o r e d for his " m a j o r c o n -
t r i b u t i o n s to a r t h r i t i s research i n the 
fields o f c l inical e p i d e m i o l o g y and c l i n i -
cal tr ials design." 
T h o m a s Freddo, O D , P h D , professor 
a n d vice c h a i r m a n for Research, 
D i v i s i o n o f O p h t h a l m o l o g y at B U M C , 
received an h o n o r a r y doctor o f science 
degree f r o m the State Univers i ty o f N e w 
York. Freddo was awarded the degree for 
his research redef in ing the c u r r e n t l y 
used m o d e l for unders tanding the 
b lood-aqueous barrier , one o f the cen-
t r a l physiological pr inc iples o f the 
h u m a n eye. 
I r w i n Goldstein, M D , professor o f u r o l -
ogy, obstetrics, a n d gynecology at B U S M 
and a urologis t at B M C , has been n a m e d 
e d i t o r - i n - c h i e f o f the Journal of Sexual 
Medicine, the new of f i c ia l j o u r n a l o f the 
I n t e r n a t i o n a l Society for Sexual a n d 
Impotence Research. The j o u r n a l c o m -
municates a n d disseminates preeminent . 
peer-reviewed research a n d i n f o r m a t i o n 
o n sexual medic ine i n m e n a n d w o m e n 
to the scientific c o m m u n i t y . 
L e o n a r d Gottlieb, M D , c h a i r m a n e m e r i -
tus o f the D e p a r t m e n t o f Pathology and 
L a b o r a t o r y M e d i c i n e at B U S M , has been 
n a m e d direc tor o f H i l l e l P r o g r a m m i n g 
at B U S M . G o t t l i e b w i l l also assume the 
role o f facul ty advisor a n d direc tor o f 
the M a i m o n i d e s Society, BUSM's Jewish 
student society. 
Alice Jacobs, M D , F A H A , B U S M profes-
sor o f m e d i c i n e a n d direc tor o f the 
Cardiac Catheterizat ion Laboratory and 
I n t e r v e n t i o n a l C a r d i o l o g y at B M C , is 
serv ing as n a t i o n a l pres ident o f the 
A m e r i c a n H e a r t Assoc ia t ion f o r the 
2004 t o 2005 f iscal year. Jacobs w i l l 
serve as spokesperson for al l medica l , 
scientific, and publ i c health matters for 
the association. 
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H a r o l d Lazar , M D , B U S M professor o f 
cardiothoracic surgery, B M C director o f 
Cardiothorac ic Surgical Research, a n d 
an a t tending cardiothorac ic surgeon at 
B M C , has been elected a fe l low o f the 
A m e r i c a n Surgical Associat ion. The 
association provides a n a t i o n a l f o r u m 
for leading surgeons a n d scientists f r o m 
N o r t h A m e r i c a a n d other cont inents t o 
openly discuss the i r latest c l in ica l a n d 
research f i n d i n g s . 
Rebecca S i l l i m a n , M D , P h D , M P H , 
B U S M professor o f medic ine and chief 
o f Geriatr ics at B M C , is one o f six aca-
demic leaders n a t i o n w i d e to be selected 
f o r p a r t i c i p a t i o n i n the John A . H a r t f o r d 
Ger ia t r i c Leadership Scholars P r o g r a m 
for the 2004 to 2007 t e r m . 
Gene Stol lerman, M D , professor e m e r i -
tus o f m e d i c i n e at B U S M , and professor 
emeri tus o f heal th services at SPH, 
received the Infec t ious Diseases Society 
o f A m e r i c a 2004 M e n t o r A w a r d . The 
award recognizes i n d i v i d u a l s w h o have 
served as exemplary m e n t o r s a n d have 
been exceptional i n g u i d i n g the profes-
sional g r o w t h o f those w o r k i n g i n the 
field o f infect ious diseases. 
Sarkis Kechejian, MD '63, of Dallas, Texas, was one of eight alumni 
to receive Boston University's 2004 Alumni Award, the highest and 
most prestigious award given by the University's Alumni 
Association. The award honors those who have shown notable 
achievements in invention and research, the arts, community leader-
ship, and national and international affairs. Kechejian, a cardiolo-
gist, is president of K Clinics, 
chief executive officer and chair-
man of the board of Alliance 
Health Inc., and president of the 
Kechejian Foundation. He's also 
been a member of BUSM's Board 
of Visitors since 1998. In 2000, 
he established the Kechejian 
Family Scholarship Fund at 
BUSM, which provides support 
tor education and Armenian-
related projects. 
William Frishman, MD '69, of Scarsdale, N.Y., was elected to the 
National Board of Directors of Alpha Omega Alpha. He also 
recently co-authored two books: Current Cardiovascular Drugs 
(4th Fdition), Philadelphia, Current Medicine, 2005; and 
Complementary and Integrative Therapies for Cardiovascular 
Disease, St. Louis, FIsevier Mosby, 2005. 
Ira Papel, MD '81, of Lutherville, Md., was chosen as president-
elect of the American Academy of Facial Plastic and Reconstructive 
Surgery. His textbook. Facial Plastic and Reconstructive Surgery, is 
entering its third edition and was recently published in a Chinese 
language edition. 
Ralph CorsettI, MD '91, of River Ridge, La., associate professor 
and chief of the Section of Surgical Oncology at Tuiane University 
Health Sciences Center and Tuiane Cancer Center, was named 
Tuiane's faculty recipient of the Leonard Tow 2004 Humanism in 
Medicine Award, presented by The Arnold P. Gold Foundation. 
This award recognizes faculty members judged to be exemplary in 
their compassion, sensitivity, and competence in the delivery of 
care to patients and family members, as well as in their respect for 
colleagues. 
Neil Floch, MD '92, of Old Greenwich, Conn., has been nomi-
nated for the Dr. Meiviiie G. Magida Award, which recognizes 
young physicians who have shown a notable capacity for patient 
treatment and care and a special sensitivity to patient-physician 
relationships. A board-certified surgeon, Floch was nominated for 
the award by his professional colleagues at Norwaik Hospital. 
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A r a m Chobanian , M D , president ad 
interim o f Boston Univers i ty , recently 
part ic ipated i n the dedica t ion o f the 
Jack Spivack Center f o r B e h a v i o r a l 
Neurosciences. Jack Spivack, a 
Washington, D.C. , resident and l o n g -
t i m e member o f BUSM's B o a r d o f 
Visi tors , established an irrevocable t rus t 
that u p o n m a t u r a t i o n w i l l donate 
$7 m i l l i o n to B U S M f o r the center. 
Spivack's generous g i f t w i l l help p o s i t i o n 
B U S M as one o f the w o r l d ' s p r e m i e r 
centers for behavioral neuroscience. 
The Boston-based Nancy L u r i e M a r k s 
Foundation has c o m m i t t e d $275,000 
over a three-year p e r i o d to s u p p o r t the 
aut ism research o f Helen Tager-
Flusberg, PhD. Tager-Flusberg is a 
B U S M professor o f a n a t o m y a n d n e u r o -
b io logy and director o f the school's 
A u t i s m Research Center o f Excellence, 
w h i c h was recently established w i t h an 
$8.4 m i l l i o n grant f r o m the N a t i o n a l 
Institutes o f Heal th . The M a r k s 
F o u n d a t i o n f u n d i n g w i l l enable Tager-
Flusberg and her colleagues to enhance 
and expand the w o r k they are u n d e r t a k -
i n g w i t h N I H f u n d i n g . 
T h e J. T. Tai and C o m p a n y Foundation 
has awarded $30,000 to B U S M again this 
year to s u p p o r t six $5,000 scholarships 
for medical students, w i t h a preference 
for students i n the M D / P h D p r o g r a m . 
This N e w York-based f o u n d a t i o n has 
p r o v i d e d annual scholarship s u p p o r t for 
a n u m b e r o f years, and its c o m m i t m e n t 
to f inanc ia l a id for medica l students is 
underscored by its generosity to several 
medica l schools n a t i o n w i d e . The late 
Tai, a Chinese-American , was n o t e d 
b o t h for his expertise i n Asian a n t i q u i -
ties and his business acumen, w h i c h 
focused o n N e w York C i t y real estate. 
The Inst i tute o n Lifestyle and H e a l t h , 
directed by Curt i s El l i son, M D , has 
received a $50,000 grant f r o m the 
B r o w n - F o r m a n C o r p . and $25,000 f r o m 
T h e W i n e Group, I n c . E l l i son, B U S M 
professor o f medic ine and chief o f the 
Section o f Preventive M e d i c i n e and 
Epidemiology , and his colleagues s tudy 
the effects o n health o f moderate a lcohol 
c o n s u m p t i o n , par t i cu lar ly w i n e . E l l i son 
is an i n t e r n a t i o n a l l y k n o w n expert o n 
this subject and is a featured speaker at 
f o r u m s w o r l d w i d e . 
Pharmaceutical companies continue to 
s u p p o r t research at B U S M . F o l l o w i n g 
are some examples o f this suppor t : 
Celgene C o r p . p a i d $336,000 to c o n -
t i n u e f u n d i n g the research pro jec t 
" E v a l u a t i o n o f T h a l i d o m i d e Fetal 
Exposure P r e v e n t i o n P r o g r a m " ; 
R a n b a x y Pharmaceut ica ls gave 
$697,256 i n c o n t i n u i n g support o f the 
m u l t i - y e a r pro jec t "Survey o f 
I s o t r e n i n o i n Use i n W o m e n " ; McNei l 
Laboratories p r o v i d e d $80,000 to sup-
p o r t the " M c N e i l A w a r d " ; Merck's 
M e d i c a l E d u c a t i o n F u n d at B U S M 
received $75,000; and A u x i l i u m 
Pharmaceuticals Inc . gave $35,000 for 
a "Sexual M e d i c i n e Fellowship." 
The Scleroderma Foundat ion has 
p r o v i d e d $30,000 i n s u p p o r t o f the 
" I n t e r n a t i o n a l W o r k s h o p o n Sclero-
derma Research Fund. " This f o u n d a t i o n 
has been a l o n g - t i m e par tner w i t h 
researchers at B U S M i n w o r k i n g t o w a r d 
i d e n t i f y i n g the causes, effective treat-
ments , and cures for scleroderma, a 
p a i n f u l a n d d i s f i g u r i n g disease that is 
one o f the m a n y f o r m s o f a r t h r i t i s . 
H a r o l d Lazar, M D , professor o f cardio-
thoracic surgery at B U S M , and director 
o f Card io thorac i c Surgical Research and 
an a t tending cardiothorac ic surgeon at 
B M C , recently received a $181,000 grant 
f r o m the A m e r i c a n Heart Association 
to i m p r o v e outcomes i n diabetic 
patients d u r i n g a c o r o n a r y artery bypass 
graft procedure by o p t i m i z i n g b l o o d -
sugar levels. 
Thomas Perls, M D , M P H , associate p r o -
fessor o f m e d i c i n e i n the Ger ia t r ics 
Section at B U S M a n d director o f the 
N e w E n g l a n d C e n t e n a r i a n S tudy 
( N F C S ) at B o s t o n U n i v e r s i t y M e d i c a l 
Center, recently received a five-year, 
$3.7 m i l l i o n grant f r o m the National 
Institutes of Health to support ongoing 
research o f exceptional longevity among 
families w i t h at least one l i v i n g cente-
nar ian . The N F C S is the largest genetic 
and social s tudy o f centenarians a n d 
their families i n the w o r l d . 
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Presidential search 
committee appointed 
This past f a l l , the B o a r d o f Trustees 
a p p o i n t e d eight o f its members to a 
15-person search c o m m i t t e e that w i l l 
r e c o m m e n d candidates for the Boston 
U n i v e r s i t y ( B U ) presidency. T h e 
r e m a i n i n g seven m e m b e r s were 
a p p o i n t e d i n N o v e m b e r a n d inc lude 
representatives f r o m the faculty, student 
b o d y , a n d deans. 
The search c o m m i t t e e w i l l be 
chaired b y D a v i d D'Alessandro, chair-
m a n a n d C E O o f John H a n c o c k 
Financia l Services. Vice c h a i r m a n w i l l be 
Robert K n o x , senior m a n a g i n g director 
o f Corners tone E q u i t y Investors, EEC. 
D'Alessandro a n d K n o x are co-vice 
c h a i r m e n o f the f u l l b o a r d . The c o m m i t -
tee also w i l l inc lude trustees Suzanne 
Cutler , D a v i d Myers , Sharon Ryan, 
Richard Shipley, a n d M a r s h a l l Sloane. 
Trustee C h a i r m a n A l a n Leventhal w i l l 
serve o n the c o m m i t t e e ex officio. 
The other seven members inc lude : 
student representative MaryGrace 
H e n r y ; facul ty members Robert Bone, 
I D , Bennett G o l d b e r g , M S , P h D , Joseph 
Foscalzo, M D , P h D , Rona ld Richardson, 
M A , P h D , a n d Rosanna W a r r e n , M A ; 
a n d Louis Fataif, dean o f the School o f 
Management . 
" U l t i m a t e l y , the Board o f Trustees is 
responsible for selecting a new president," 
says D'Alessandro. " T h a t is n o t some-
t h i n g we can or should delegate. But the 
search commit tee , w i t h its inclusive 
process and diverse membership , w i l l 
make sure that selection is based o n the 
m a n y needs and the dif ferent perspectives 
f r o m across the entire university." 
Leventhal says the c o m m i t t e e w i l l 
c o n d u c t a systematic a n d inclusive 
search. " I have no d o u b t i t w i l l succeed 
i n i d e n t i f y i n g n u m e r o u s o u t s t a n d i n g 
candidates to lead this i n s t i t u t i o n i n t o 
its next phase o f g r o w t h a n d develop-
ment , " he says. 
Since last N o v e m b e r , the U n i v e r s i t y 
has been headed b y President ad 
interim A r a m C h o b a n i a n , M D , f o r m e r l y 
dean o f the School o f M e d i c i n e a n d 
provos t o f the M e d i c a l C a m p u s . 
C h o b a n i a n is n o t a candidate f o r the 
p e r m a n e n t presidency. 
BU student named 2005 
Rhodes Scholar 
Anastasia Pil iavsky, a 2004 B U graduate, 
has received a Rhodes Scholarship, j o i n -
i n g 31 other A m e r i c a n m e n a n d w o m e n 
chosen as 2005 Rhodes Scholars. The 
23-year -o ld Pi l iavsky earned a bache-
lor's degree f r o m BU's College o f A r t s 
a n d Sciences last s p r i n g , g r a d u a t i n g 
summa cum iaude w i t h a d o u b l e m a j o r 
i n r e l i g i o n a n d a n t h r o p o l o g y . She w i l l 
enter O x f o r d U n i v e r s i t y i n October , 
s t u d y i n g to earn her master's i n v isua l 
a n t h r o p o l o g y . 
"Rhodes Scholarships are given n o t 
o n l y for o u t s t a n d i n g inte l lec t b u t also 
f o r u n u s u a l s t rength o f character a n d 
p o t e n t i a l for leadership, a n d Anastasia 
cer ta inly has al l o f these," says Jeffrey 
H e n d e r s o n , dean o f BU's College o f 
A r t s and Sciences. "Anastasia's success 
reflects w o n d e r f u l l y o n the q u a l i t y o f 
o u r u n i v e r s i t y a n d the college, b o t h aca-
demica l ly a n d i n terms o f the character 
o f o u r students a n d t h e i r p r o m i s e f o r 
success." 
Ted Koppel wins BU 
Inaugural journalism award 
BU's College o f C o m m u n i c a t i o n 
awarded the f i rs t a n n u a l H u g o S h o n g 
L i f e t i m e J o u r n a l i s m A c h i e v e m e n t 
A w a r d to Ted K o p p e l , a 40-year veteran 
o f A B C News a n d a n c h o r o f television's 
f i r s t l a t e - n i g h t n e t w o r k news p r o g r a m , 
Nightiine. T h e a w a r d is presented b y 
BU's College o f C o m m u n i c a t i o n to a 
p r i n t or broadcast j o u r n a l i s t whose 
b o d y o f w o r k a n d c o n t r i b u t i o n s to the 
field e x e m p l i f y the highest q u a l i t y o f 
r e p o r t i n g a n d analysis, o u t s t a n d i n g 
accompl i shments , a n d e th ica l s tandards 
o f the j o u r n a l i s t i c profess ion . B U a l u m -
nus H u g o Shong, w h o established the 
pr ize , presented the a w a r d d u r i n g a 
d i n n e r r e c e p t i o n . 
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NSF awards $20.1 million 
for Interdisciplinary science 
of learning center 
The Nat iona l Science F o u n d a t i o n (NSF) 
awarded Boston U n i v e r s i t y ( B U ) profes-
sor Stephen Grossberg, P h D , a five-year, 
$20.1 m i l l i o n grant to l aunch the Center 
for Learning i n E d u c a t i o n , Science, and 
Technology (CELEST) at B U . The cen-
ter's mandates are to unders tand better 
h o w the b r a i n operates a n d to develop 
educational tools to advance the teach-
i n g o f b r a i n science i n h i g h schools and 
universities a r o u n d the w o r l d . 
CELEST w i l l synthesize a n d c o o r d i -
nate several research agendas. Based i n 
the D e p a r t m e n t o f Cogni t ive a n d N e u r a l 
Systems (CNS) at the College o f A r t s 
and Sciences (CAS) , the new center w i l l 
p u l l together scientists, educators, a n d 
technologists f r o m CNS, the CAS 
Departments o f Mathemat ics a n d 
Psychology, and the College o f 
Engineering's ( E N G ) D e p a r t m e n t o f 
Biomedical Engineer ing. I t also w i l l 
involve researchers at the Center f o r 
Adaptive Systems, the Center f o r 
M e m o r y and the B r a i n , the Science a n d 
Mathematics Educat ion Center, the 
Hear ing Research Center, and the Center 
for Polymer Studies. O t h e r CELEST co l -
laborators include facul ty at Brandeis 
University, M I T , and the U n i v e r s i t y o f 
Pennsylvania. 
Grossberg holds professorships i n 
the CAS Depar tments o f Cogni t ive and 
N e u r a l Systems, Mathemat ics , and 
Psychology, and i n the E N G D e p a r t m e n t 
o f B iomedica l Engineer ing. He also is 
f o u n d i n g director o f the Center for 
Adapt ive Systems and f o u n d i n g chair-
m a n o f CNS. 
BU mathematician named 
Massachusetts professor 
of the year 
Robert Devaney, P h D , B U professor o f 
mathematics a n d statistics, was n a m e d 
2004 Massachusetts Professor o f the Year 
by the Carnegie E o u n d a t i o n for the 
Advancement o f Teaching and the 
C o u n c i l for the Advancement a n d 
Suppor t o f Educat ion . 
A w i d e l y respected expert i n c o m -
plex d y n a m i c a l systems, Devaney has 
also achieved acclaim for his p i o n e e r i n g 
use o f technology i n teaching. H e has 
d i rec ted the N a t i o n a l Science E o u n -
dation's (NSF) D y n a m i c a l Systems and 
Technology Project since 1989, a pro ject 
that helps h i g h school and college e d u -
cators use technology to teach m o r e 
effectively such m o d e r n mathematics as 
chaos, fractals, and dynamics . H e was 
the first mathemat i c ian to w i n the NSF 
Director 's A w a r d for Dis t inguished 
Teaching Scholars (2002) and received 
the M a t h e m a t i c a l A s s o c i a t i o n o f 
America ' s Teacher o f the Year A w a r d 
(1995) . I n 2003, Devaney also received 
BU's M e t c a l f A w a r d f o r Excellence i n 
Teaching. 
Simpson named director 
of CFA's School of 
Visual Arts 
The College o f Fine A r t s (CFA) 
a p p o i n t e d Judi th S i m p s o n , an associate 
professor and c h a i r m a n o f the A r t 
E d u c a t i o n D e p a r t m e n t , as d i rec tor o f its 
School o f Visua l A r t s . S impson , whose 
p r i m a r y research interest is the role o f 
art educat ion i n u r b a n schools, had been 
the school's d i rec tor ad interim for the 
2003 to 2004 academic year. Last year, 
she established a v i s i t i n g artist p r o g r a m 
at the school , catalogued its col lect ion o f 
archived w o r k , a n d u n d e r t o o k a c u r r i c u -
l u m review. 
S impson j o i n e d the visual arts fac-
u l t y as an assistant professor i n 1996, 
was p r o m o t e d to associate professor i n 
1998, a n d became c h a i r m a n o f the A r t 
E d u c a t i o n D e p a r t m e n t i n 2001. She has 
degrees f r o m the U n i v e r s i t y o f N e w 
H a m p s h i r e a n d the Massachusetts 
College o f A r t , a n d a P h D f r o m the 
U n i v e r s i t y o f W i s c o n s i n . H e r director 
p o s i t i o n is a two-year a p p o i n t m e n t . 
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Mary Walsh, PhD, o f Walpole , Mass., 
o n August 15, 2004, at the age o f 52. 
D r . Walsh was an associate professor o f 
physio logy a n d biophysics at Boston 
U n i v e r s i t y School o f M e d i c i n e ( B U S M ) , 
and direc tor o f research at the school's 
A m y l o i d Research a n d Treatment 
P r o g r a m . 
D r . Walsh received her u n d e r g r a d u -
ate degree i n chemis t ry f r o m S i m m o n s 
College a n d her P h D i n chemis t ry f r o m 
B r o w n Univers i ty . She was recrui ted to 
B U S M a n d j o i n e d the l a b o r a t o r y o f 
D a v i d A t k i n s o n , P h D , as a pos tdoctora l 
biophysics trainee i n 1980. She remained 
Atkinson 's co-investigator a n d was c o m -
m i t t e d to the u n d e r s t a n d i n g o f the 
molecular complexit ies involved i n p r o -
te in f o l d i n g and s tabi l i ty i n cardiovascu-
lar a n d a m y l o i d diseases u n t i l her death. 
D r . Walsh made substantial c o n t r i -
b u t i o n s to the development o f the 
Biophysics Depar tment ' s graduate p r o -
g r a m a n d its research e n v i r o n m e n t as a 
w h o l e . She also c o n t r i b u t e d to the 
g r o w t h a n d expansion o f the graduate 
d i v i s i o n , i n c l u d i n g the establishment o f 
its policies a n d procedures i n 1992. 
H e r c o m m i t m e n t to the t r a i n i n g 
and teaching o f graduate and medica l 
students was unceasing, and she cons id-
ered i t her m i s s i o n to guide and counsel 
students. D r . Walsh was respected by her 
colleagues a n d students alike a n d w i l l be 
remembered f o r her unself ish c o n t r i b u -
t ions o f t i m e a n d e f for t i n every aspect 
o f academic l i fe . 
She is surv ived b y her husband, 
Gary A n d e r s o n , three brothers , a n d sev-
eral nieces a n d nephews. 
A L U M N I 
Constance Cincotti, MD '35, o f 
O t i s f i e l d , M a i n e , o n July 4, 2004, at the 
age o f 92. A psychiatr ist f o r 38 years, 
D r . C i n c o t t i pract iced at the Veterans 
A d m i n i s t r a t i o n i n Boston and N o r t h -
a m p t o n , Mass., before re t i r ing i n 1995 to 
O t i s f i e l d , M a i n e . She was a senior c l i n i -
cal i n s t r u c t o r at Tufts U n i v e r s i t y School 
o f M e d i c i n e , and was a m e m b e r o f the 
A m e r i c a n Psychiatric Associat ion a n d 
the Massachusetts M e d i c a l Society. 
D r . C i n c o t t i was the w i f e o f C o l . John 
C i n c o t t i , M D ( B U S M '35) , w h o passed 
away i n 1969. She is surv ived by f o u r 
c h i l d r e n , three g r a n d c h i l d r e n , a n d one 
great- g r a n d c h i l d . 
William Croskery, MD '37, o f Peabody, 
Mass., o n September 22, 2004, at the age 
o f 94. A surgeon a n d a br igadier general 
i n the A i r Force Reserves, D r . Croskery 
demonstra ted a passion for serving o t h -
ers. H e enlisted i n the A r m y A i r Corps , 
serving as chief f l i g h t surgeon i n the 
Alaskan-Siberian D i v i s i o n . H e later 
became chief f l i g h t surgeon w i t h the 
Massachusetts A i r N a t i o n a l G u a r d 102d 
Tactical Fighter W i n g , eventual ly earn ing 
the r a n k o f br igadier general i n the 
Reserves. H e served i n Korea a n d 
V i e t n a m as w e l l . 
D r . Croskery h a d a pr ivate practice 
i n B r o o k l i n e , Mass., a n d was o n staff at 
U n i v e r s i t y H o s p i t a l ( n o w Boston 
M e d i c a l Center ) , Faulkner H o s p i t a l , a n d 
St. Flizabeth's H o s p i t a l . H e was a m e m -
ber o f the H a r v a r d C l u b a n d the A n c i e n t 
a n d H o n o r a b l e A r t i l l e r y C o m p a n y o f 
Massachusetts, a n d he was a past presi -
dent o f the B U S M A l u m n i Associat ion, 
class agent f o r the Class o f 1937, a n d a 
dedicated P h o n a t h o n volunteer . H e was 
also a m e m b e r o f the L Street Brownies 
i n South Boston , w h o are f a m o u s f o r 
the i r dips i n t o the f r i g i d waters o f 
Boston H a r b o r o n N e w Year's Day. I n 
1977, fr iends h o n o r e d D r . Croskery by 
establishing the W i l l i a m F. Croskery, 
M D , Emergency Foan F u n d at B U S M . 
H e is survived b y his w i f e , P r u n g s u k o r n 
C h u m p o o - C r o s k e r y , a n d m a n y nieces, 
nephews, grandnieces, a n d g r a n d -
nephews. 
Angelo Mastrangelo, Jr., MD '39, o f 
W i l m i n g t o n , N . C . , a n d f o r m e r l y o f 
S tamford , C o n n . , o n A u g u s t 2, 2004, at 
the age o f 92. D r . Mastrange lo , w h o was 
k n o w n by m a n y as D r . A l , was recog-
nized as one o f Stamford's m o s t 
respected citizens, c o m m u n i t y leaders, 
a n d physicians. H e w o r k e d w i t h a n d 
suppor ted the S t a m f o r d H o s p i t a l a n d its 
af f i l iated entities i n m a n y capacities f o r 
m o r e t h a n 60 years. D r . Mast range lo 
organized the f irst Poison C o n t r o l 
Center i n C o n n e c t i c u t , served as chair -
m a n o f S t a m f o r d Hospice Care Inc . , a n d 
was an active m e m b e r o f the S t a m f o r d 
A I D S Task Force. H e also was c h a i r m a n 
o f the Board o f the Center f o r 
C o n t i n u i n g Care o f Greater S t a m f o r d 
a n d c h a i r m a n o f the Tandet Center f o r 
C o n t i n u i n g Care. 
D u r i n g W o r l d W a r I I , D r . 
Mastrangelo served i n the U.S. A i r Force 
as a f l i g h t surgeon a n d received the A i r 
M e d a l , Bronze Star, a n d Presidential 
U n i t C i t a t i o n . H e is surv ived b y his w i f e 
o f 59 years, Lois , five c h i l d r e n , his sister, 
f o u r g r a n d c h i l d r e n , a n d one great-
grandson . 
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Frank Zsoldos, MD '39, o f Beckley, 
W.Va. , o n July 17, 2004, at the age o f 9 1 . 
Dr . Zsoldos began his 47-year practice i n 
the c o a l - m i n i n g areas o f Glen Rogers, 
Pinevil le , and M u l l e n s , W.Va. , a n d later 
became chief o f staff at W y o m i n g 
General Hospi ta l i n M u l l e n s . H e was a 
life fe l low o f the A m e r i c a n A c a d e m y o f 
A b d o m i n a l Surgeons a n d the A m e r i c a n 
Association o f Fami ly Pract i t ioners . 
Dr . Zsoldos was also president o f the 
W y o m i n g C o u n t y Cancer Society and a 
member o f the West V i r g i n i a State 
Cancer Board for eight years. H e organ-
ized the Bluefield Deanery C o u n c i l o f 
Catholic Physicians and was its f irst pres-
ident. He is predeceased b y his w i f e o f 66 
years, Irene, a sister, t w o brothers , and a 
grandson, and is survived by t w o sons, 
t w o daughters, his brother , n i n e g r a n d -
chi ldren, and t w o great -grandchi ldren. 
Robert Cooney, MD '48, o f Portage, 
Wis . , o n June 3, 2004, at the age o f 80. A 
general pract i t ioner u n t i l his re t i rement 
i n 1999, Dr . Cooney made house calls 
and delivered several generations o f 
babies. He served i n the U.S. A r m y d u r -
i n g W o r l d War I I , and he he ld the r a n k 
o f captain as a surgeon i n the M e d i c a l 
Corps i n Korea d u r i n g the Korean War. 
H e was also a m e m b e r o f the A m e r i c a n 
Medica l Associat ion a n d the M e d i c a l 
Society o f Wiscons in . H e is survived by 
his w i f e , Judi th , three sons, three sisters, 
t w o g r a n d c h i l d r e n , and m a n y nieces a n d 
nephews. 
Ames Robey, MD '56, o f Stoneham, 
Mass., o n September 23, 2004, at the age 
o f 75. A forensic psychiatrist . Dr . Robey 
advised courts o n the competency o f 
accused persons to s tand t r i a l . H e 
became widely k n o w n for his role as the 
psychiatrist i n the Boston Strangler 
invest igat ion. I n 1967, he f o u n d e d the 
Center for Forensic Psychiatry for the 
State o f M i c h i g a n . A n enthusiastic 
teacher, he also publ i shed o n a b r o a d 
range o f topics. H e is survived b y his 
w i f e , V i r g i n i a , f o u r daughters, his sister, 
and a large extended f a m i l y o f g r a n d -
c h i l d r e n , nieces, and nephews. 
Joseph Ruscio, MD '57, o f Bradenton, 
Fla., o n August 3 1 , 2004, at the age o f 76. 
D r . Ruscio was an i n s t r u c t o r and assis-
tant professor o f anesthesia at H a r v a r d 
M e d i c a l School, chief o f anesthesia and 
respiratory therapy at Q u i n c y C i t y 
H o s p i t a l , and a f o r m e r associate profes-
sor o f anesthesia at C r e i g h t o n U n i v e r -
sity. H e served i n the U.S. Navy f r o m 
1946 to 1950. H e also was a m e m b e r o f 
the Massachusetts M e d i c a l Society, the 
Massachusetts Society o f Anesthesiol-
ogists, a n d the A m e r i c a n Society o f 
Anesthesiologists, a n d he served as pres-
i d e n t o f the N e w E n g l a n d Society o f 
Anesthesiologists. H e is survived by his 
w i f e , J u d i t h , t w o daughters, a son, a 
stepson, a sister, a brother , and seven 
g r a n d c h i l d r e n . 
Mario Scuico, MD '60, o f N o r w i c h , 
C o n n . , o n July 3, 2004, at the age o f 69. 
D r . Scuico was a b o a r d - c e r t i f i e d n e u r o -
surgeon a n d was o n the staff o f the 
W i l l i a m W . Backus Hospi ta l i n N o r w i c h , 
C o n n . , where he establ ished the 
D e p a r t m e n t o f Neurosurgery . H e served 
as N o r w i c h ' s sole neurosurgeon for 25 
years a n d was responsible f o r the i n i t i a -
t i o n o f neurosurgica l t r a i n i n g p r o g r a m s 
for the n u r s i n g staff as w e l l . H e is sur-
v i v e d b y his w i f e o f 43 years, Lois, t w o 
sons, one daughter , his brother , t w o sis-
ters, a n d f o u r g r a n d c h i l d r e n . 
Theodore Stamas, MD '62, o f 
H i n g h a m , Mass., o n September 3, 2004, 
at the age o f 7 1 . A n o p h t h a l m o l o g i s t . 
D r . Stamas p r a c t i c e d i n H i n g h a m f o r 
m o r e t h a n 40 years. H e enlisted i n the 
A r m y a n d later served as a medical officer 
o n his second t o u r o f duty. H e is survived 
by his w i f e , Eileen, a son, and a brother. 
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